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ABSTRACT  
   
Objective:  This research examined the effectiveness of a weight loss diet 
incorporating high protein pasta and breakfast cereal products as compared to a weight 
loss diet using conventional versions of gluten-free pasta and breakfast cereal. 
 Design:  In a 6-week parallel-arm food trial (representing the first phase of a 12-
week cross-over trial), 26 overweight and obese (Mean BMI 43.1 ± 12.4 kg/m²) 
participants, free of related comorbidities, were randomly assigned to the Zone diet 
(~29% energy intake from protein) or a control diet (~9% energy from protein). 
Participants were included in the trial if they satisfied the criteria for elevated risk for 
metabolic syndrome (top half of the TG/HDL ratios of all who were tested). Participants 
were instructed to eat prepared meals (total of 7 cereal packets and 14 pasta meals 
weekly) that included patented food technologies for the Zone diet and commercially 
available gluten-free rice pasta and a conventional name brand boxed cereal for the 
control diet. Body composition was measured with a bioelectrical impedance scale at 
weeks 1, and 6. Food records and diet adherence were recorded daily by the participants. 
 Results:  Both the Zone and control diets resulted in significant weight loss (-2.9 
± 3.1 kg vs. -2.7 ± 2.6 kg respectively) over time (p = 0.03) but not between groups (p = 
0.96). Although not statistically significant, the Zone diet appears to have influenced 
more weight loss at trial weeks 3, 4, and 5 (p = 0.46) than the control diet.  The change in 
FFM was significant (p = 0.02) between the Zone and control groups (1.4 ± 3.6 kg vs. -
0.6 ± 1.5 kg respectively) at week-6. Study adherence did not differ significantly between 
diet groups (p = 0.53). 
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Conclusions:  Energy-restricted diets are effective for short-term weight loss and 
high protein intake appears to promote protein sparing and preservation of FFM during 
weight loss. The macronutrient profile of the diet does not appear to influence calorie 
intake, but it does appear to influence the quality of weight loss.  Other measures of body 
composition and overall health outcomes should be examined by future studies to 
appropriately identify the potential health effects between these diet types.  
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CHAPTER 1 
INTRODUCTION 
Although the rise of BMI-defined overweight and obesity in the United States 
(U.S.) over the past 35 years appears to be leveling off, nearly 70% of adults are currently 
overweight or obese.  In 2010, more than a third (35.9%) of the country was categorized 
as obese, representing more than 78 million adults (1, 2).  These statistics are staggering 
considering obese individuals spend more on healthcare than their normal-weight 
counterparts. In 2008, obese related healthcare expenses equaled $146 billion, including 
nearly 50% higher inpatient costs, more than a quarter (27%) increase in outpatient 
expenses, and 80% more spent on prescription drugs compared to normal-weight 
individuals (3).  In addition to increased medical costs, obesity increases risk of all-cause 
mortality and morbidity from type 2 diabetes, hypertension, coronary heart disease, 
stroke, dyslipidemia and some types of cancers among a much longer list of associated 
diseases (4).  
 The prevalence of overweight and obesity within the U.S. changed little between 
1960 and 1980 but began to rise steadily in the 80’s and 90’s and tapered off around 2003 
to near current levels (1). The trend in the growing circumference of the population 
sparked a weight loss industry projected at $66 billion in the U.S. in 2013 including a 
vast array of new diets, services, and surgical procedures to manage the problem of 
ballooning proportions (5).  With more than 100 million Americans initiating 4 to 5 
weight loss diet attempts a year, the obesity management industry is projected to continue 
to grow near its historical average around 6% per year (5).   
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Creator of the Zone Diet, Dr. Barry Sears, argues that the obesity epidemic started 
around 1980 when government nutrition boards and scientific panels labeled a healthy 
diet as one low in the macronutrients fat and protein and high in carbohydrates (6). He 
believes that the country was part of an unsubstantiated social experiment created around 
these purported healthy recommendations and as a result, the population began to swell. 
This counterargument, as portrayed by the Zone Diet, is that a healthy diet contains a 
balanced macronutrient profile: moderate amounts of fat, carbohydrate, and protein (30, 
40, and 30 percent energy respectively) (6).The Zone Diet has successfully marketed 
numerous food products with the intent to balance the macronutrient intake inline with its 
macronutrient recommendations. The proposed research will examine the weight loss 
efficacy of new Zone products, reengineered pasta and breakfast cereal products with 
balanced macronutrient profiles, as compared to conventional cereal and low gluten 
pasta. 
Purpose of Study 
The objective of this research is to identify the effectiveness of weight loss diets 
incorporating high protein pasta and breakfast cereal products as compared to weight loss 
diets using conventional versions of gluten-free pasta and breakfast cereal. The published 
literature suggests protein is more satiating than both carbohydrate and fat in both the 
short and long term (7).  Additionally, high protein diets, irrespective of the protein 
source, appear to reduce total energy intake as a result of greater satiety (8, 9).  However, 
a systematic review of randomized controlled trials (RCTs) of popular diets (Atkins, 
South Beach, Weight Watchers, and Zone) over a period of one year demonstrated they 
all achieved similarly modest weight loss regardless of macronutrient profiles (10). The 
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authors suggested the data reviewed from the RCTs were conflicting and the lack of true 
head-to-head comparisons resulted in the inability to identify any of the diets as being 
superior to the others.  
Research Aim and Hypotheses 
 Based on reported mechanisms linking protein intake with satiation and weight 
loss (11), three hypotheses are proposed: 
Hypothesis 1 
The high protein (Zone pasta and cereal) diet will result in greater weight loss as 
compared to a diet incorporating gluten-free pasta and cereal. 
Hypothesis 2  
The high protein diet will support protein sparing resulting as indicated by a lower 
loss of lean mass. 
Hypothesis 3 
The increased satiety effect of protein will promote greater adherence to the diet 
with higher levels of protein.  
Delimitations and Limitations 
Volunteers for the study were directed to an online survey which was designed to 
address inclusion and exclusion criteria. Volunteers who met these criteria were eligible 
to participate in the study.  Following strict eligibility criteria ensured intervening 
variables were held to a minimum when assessing the final results from the weight loss 
trial. Only apparently healthy individuals with no history of food allergies or dietary 
restrictions were eligible. Cigarette use, insulin use, and active disease states excluded 
individuals from participation.  A total of 43 qualified participants were enrolled with the 
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target goal of completing the study with at least 25 participants, understanding expected 
attrition rates associated with feeding trials.  All participants had their basal metabolic 
rate calculated (Mifflin-St. Jeor equation) and received a personalized calorie intake 
range with suggested additional food items to promote a 1-2 pound per week weight loss. 
Each participant received a total of 14 pasta meals and 7 cereal packets every week 
during the 12-week trial. The macronutrient profiles of the test foods varied by study 
group: macronutrient balanced or high carbohydrate/low protein.  
The length of study presented challenges to the participants as 12 weeks 
represents an extensive time period to adhere to the trial and its goals. (Note:  the 
research presented herein focuses on the data from the first 6 week phase of a 12 week 
crossover trial.)  Participants were instructed to pick up their meals on a weekly basis 
which may have been challenging over the duration of the trial. Additionally, researchers 
have indicated food studies which are conducted over longer periods of time tend to 
result in gradually diminishing palatability ratings which could present adherence 
difficulties for participants eating the same foods every week regardless of protein 
content (12). It is believed a fair amount of attrition was to be expected with a trial of this 
duration based on the extent participants favor the food they receive.  Participants self 
monitored their diet intake and behavior during the trial. 
Definitions 
Basal Metabolic Rate (BMR) – The minimal energy expenditure at rest (based on the 
Mifflin-St.Jeor equation). 
Women: BMR = (10 x weight {kg}) + (6.25 x height {cm}) - (5 x age {yrs}) - 161  
Men: BMR = (10 x weight {kg}) + (6.25 x height {cm}) - (5 x age {yrs}) + 5 
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Body Mass Index (BMI) – An index for comparing height to weight; calculated by 
dividing weight in kilograms by the square of height in meters; used to determine 
weight status. 
Body Fat Percentage – Total percent of body fat compared to total weight. Measured with 
the Tanita scale via electrical impedance.  
Lean Body Mass – Total body weight minus weight from body fat. Measured with the 
Tanita scale via electrical impedance. 
Overweight – BMI range in adults between 25 kg/m² and 29.9 kg/m². 
Obesity – BMI range in adults ≥ 30 kg/m².  
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Chapter 2 
REVIEW OF LITERATURE 
State of Obesity 
Prevalence of Obesity.  The National Center for Health Statistics stated nearly 
two-thirds of the population was classified as overweight (BMI 25-29.9 kg/m²) or obese 
(BMI ≥ 30 kg/m²) in 2004 but less than half of the population had the same classification 
in 1980 (13). According to data recorded from the National Health and Nutrition 
Examination Survey (NHANES), in 2008 the prevalence of obesity in the U.S. was 
recorded at 33.8% (78 million adults) of the population, representing more than 100% 
increase in obesity from the time the survey was conducted from 1976 to 1980 (15% 
obese) (14).  Using BMI classifications for overweight and obese, little change in 
population weight status was recognized from 1960 through 1980 according to a 
comparison of the National Health Examination Survey (NHES I, 1960 – 1962) and 
NHANES (15).  This trend changed dramatically after 1980, and by the time of the 1988-
1994 NHANES was completed, an 8% increase in obesity was identified (16).  A similar 
rise was again noted by the survey from 1999-2000 but this trend has leveled over the 
past decade (1). 
 As the population becomes more rotund, a greater share of the annual healthcare 
costs will need to be allocated to the management of overweight and obesity related 
health problems. These health problems are primarily the result of serious endocrine and 
metabolic changes that include type 2 diabetes, heart disease, and increased cancer risks. 
In addition to these ailments, obese individuals tend to have a lower quality of life, an 
increase in mortality and morbidity, and more functionally limiting restrictions (17). It is 
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difficult to project annual expenditures on the healthcare system as both direct and 
indirect costs are associated with this problem. Using data from the Medical Expenditure 
Panel Survey (MEPS), one group of researchers estimated that the cost to the U. S. was 
$147 billion dollars in 2008 which represented 9.1% of all healthcare expenditures that 
year (3).  However, an earlier publication adjusted the MEPS data to factor in the weight 
of the respondents’ biological relatives and found the impact of obesity on annual 
healthcare costs may have reached $190.2 billion (20.6% of total expenditure) by the year 
2005 (18).  Forecasting the prevalence of obesity through to the year 2030, a recent 
publication used regression modeling to project that the rate of obesity will increase to 
about 42% of the population, representing an estimated increase of about $550 billion in 
healthcare expenditures compared to 2010 levels (19).  Others using more optimistic 
models suggest that obesity will plateau at 32% of the population by 2030 regardless of 
intervention strategies (20). 
Dietary Guidelines.  The contention from the Zone Diet is that the recent obesity 
epidemic stemmed from the primary dietary wisdom over the past 35 years which has 
espoused a low fat, low protein, and high carbohydrate diet as the proper ratio for a 
healthy and balanced nutritional approach (6). The argument in favor of a paradigm shift 
in our nutritional recommendations dictates that this dietary “wisdom” sparked a social 
experiment that is directly correlated to the rise in obesity recorded over this time period. 
Based upon the high carbohydrate model, the U.S. Department of Health and Human 
Services (HHS) and the U.S. Department of Agriculture (USDA) jointly launched the 
Dietary Guidelines for Americans (DGA) in 1980 and have published updates every 5 
years (21). The macronutrient profile presented within these guidelines recommends that 
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45% to 65% of total calories comprise of carbohydrates, while 20% to 35% should come 
from fat, and the remaining 10% to 15% of calories from protein (22).   
In 1997, the Dietary Reference Intakes (DRI) was founded with the 
recommendations from the Institute of Medicine and the National Academy of Sciences 
to establish quantitative estimates for dietary intake for healthy individuals. As part of the 
DRI, Acceptable Macronutrient Distribution Ranges (AMDRs) were created with a 
similar macronutrient profile to the DGA with one major difference. The range as a 
percent of energy for protein was increased up to 35% of total calories for adults (23).  
The increase in protein intake highlights a move from the traditional wisdom of the recent 
past but fails to leave behind the backbone of the high carbohydrate model. The trends in 
obesity began to level at the turn of the century, only a few years after the DRI had 
established new recommendations for a healthy diet (1). However, it is unlikely the 
higher protein recommendation had anything to do with the leveling obesity trend as 
Americans consume an average of 50% of their total calories from carbohydrates, 33% 
from fats, and about 15% from proteins which is consistent with both the DGA and DRI 
recommendations (24). 
Standard American Diet.  The rise in overweight and obesity in the U. S. 
coincides with the release of macronutrient recommendations from the government but is 
more likely connected to an increase in per capita caloric intake associated with the 
increase in food availability.  The standard American diet (SAD) began to change when 
the availability of food increased substantially resulting in a significant increase in 
average caloric intake (24). According to the USDA’s Economic Research Service 
(ERS), Americans consumed about 1,900 kcal per day in the 1950’s and this intake level 
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rose to over 2,600 kcal per day by 2008 (25).  The ERS noted that the bulk of this 
increase occurred from 1970 to 2000 which is within a similar timeframe coinciding with 
the rise in obesity.  Grains (9.5 % increase), added fats (9% increase), and added sugars 
(4.7% increase) comprised the most significant increase in calories to the SAD during 
this time period which helps to explain why protein comprises only about 15% of the 
average diet (24). The abundance and accessibility to foods and beverages with added 
sugars and fats combined with a seemingly reduced availability of nutrient-dense options 
may offer a more plausible explanation for the sharp increase in weight gain over the past 
four decades (26).  
Mechanisms of Protein and Satiety 
 The increase in average caloric intake of the SAD may be a result of the addition 
of carbohydrates and fats into the diet without a similar increase in caloric intake from 
proteins.  Overweight and obesity is a reflection of a diet that results in a positive energy 
balance or one where more calories are consumed than used in a given time period. 
Protein appears to have an increased satiety response when compared to carbohydrates 
and fats. The SAD may be a reflection of this effect as a reduction in the percentage of 
protein intake essentially inhibits its feeling of satiety for the other more readily 
accessible macronutrients. Increasing protein availability and intake into the diet should 
result in higher levels of satiety and help restore the energy balance equation.  Several 
factors are associated with protein-induced satiety and its potential for weight loss. 
Protein increases energy expenditure through the thermic effect of food (TEF), and 
appears to increase hormones and metabolites that reduce hunger.  Therefore, an increase 
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in protein intake may help the energy balance equation by both enhancing satiety 
(reducing intake) and increasing calorie output (27). 
Diet-Induced Thermogenesis.  Protein has the highest TEF for all the 
macronutrients and thus has the highest satiating efficiency of the three followed by 
carbohydrates and lastly by fats. The TEF is measured as a percentage increase in the 
BMR and is best explained by the metabolic responses to digestion, absorption, nutrient 
transport, and the metabolism and storage of nutrients (27).  Protein was shown to have 
the highest effect (15% to 30%), followed by carbohydrates (5% to 10%) and fat (0% to 
3%) (28).  An increase in the TEF essentially dictates a greater calorie output and results 
in a positive effect on energy balance.  This increase was exemplified by researchers who 
substituted carbohydrates (about 18% of energy) with either pork or soy protein, 
producing an average of 3% increase (pork = 492 kJ/d, 3.9%, p = 0.05; soy = 244 kJ/d, 
1.9%, p < 0.05) in the 24 hour energy expenditure (29).  The control meal was 28% 
composed of fat and 11% as protein, and the test meals were composed of 28% fat and 
29% protein.  In addition to the elevated energy output, they reported participants had a 
slightly lower energy intake with the higher protein diets despite using isoenergetic 
substitutions for carbohydrates. They noted participants had a difficult time finishing the 
meals likely due to the satiating effects of protein.  
 The protein-induced satiety was also registered in combination with the increased 
thermic effect of protein by researchers measuring participants in a respiration chamber 
(30).  Using energy balanced meals, they compared the energy expenditures and satiety 
associated with high protein meal intervals (29% of total calories) and low protein meal 
intervals (9% of total calories).  They noted that participants reported greater satiety and 
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fullness throughout the day on the high protein diet and had lowered feelings of hunger, 
appetite, and desire to eat despite being unable to note significance in the amount eaten 
between the two groups. They did find a significant difference between the diet-induced 
thermogenesis from the two groups (HP = 1295 ± 240 kJ/d, LP = 931 ± 315 kJ/d; p < 
0.01), and noted a positive relationship (r = 0.8; p < 0.01) between the difference in the 
thermic effect of the diets with feelings of satiety.  Crovetti, et al., noted a similar 
relationship between the TEF and satiety comparing a series of isoenergetic meals with 
different macronutrient profiles (31). High protein (68% of energy), high carbohydrate 
(69% of energy), and high fat (70% of energy) meals were offered to a group of 10 
normal weight women and their energy expenditure was measured using indirect 
calorimetry. The high protein meal had a significantly higher TEF (261 ± 59 kJ; p < 
0.001) than both carbohydrate (92 ± 67 kJ) and fat (97 ± 71 kJ). It also registered the 
highest satiety levels of the three macronutrients. A positive relationship between TEF 
and satiety for all three meal types (r = 0.41; p = 0.025) was noted.  
 Using an ad libitum approach instead of a controlled approach to meal intake, 
Raben et al., found that meals with similar energy densities but different macronutrient 
profiles did not elicit a change on appetite or energy intake (32).  While they found a 
similar TEF as the previous researchers they did not find any relationship between energy 
expenditure and satiety. Comparing meals rich in protein (32% of energy), carbohydrate 
(65% of energy), and fat (65% of energy) on normal weight participants, they identified a 
17% increase in TEF after the protein meal but found no significance between it and the 
other two meal types. They were surprised by the results but surmised the similar energy 
densities between the meals may explain the discrepancies between their results and 
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previous studies. In an interesting twist, the participants demonstrated a lower desire for 
sweet foods after the high carbohydrate meal compared to the high protein meal.  The 
total food intake between the three groups was not significantly different however, 
suggesting that satiety and hunger may be less prone to change between the 
macronutrients when present with an ad libitum approach to eating. The results suggest 
that the macronutrient hierarchy in TEF may not coincide directly with the satiety 
hierarchy suggesting other mediating factors may be required to elucidate an increased 
satiated response to the thermic effect of protein.  
Satiety Hormones.  Other mechanisms involved with the increase in satiety 
following an increase in protein intake may help to explain the connection with the TEF.  
Hormonal changes related to protein intake and satiety may play an important role in how 
the energy balance equation is mediated within the body.  Researchers demonstrated that 
satiety related to a high protein diet was mediated through an increase in Glucagon-like 
peptide-1 (GLP-1), an appetite suppressing hormone (33).  GLP-1 inhibits the secretion 
of glucagon but also slows gut motility and gastrointestinal secretions which down 
regulates appetite, and increases satiety as a result (34).  A total of 12 healthy women 
were on an isoenergetic diet of either a low protein (10% protein, 60% carbohydrate, and 
30% fat) or a high protein (30% protein, 40% carbohydrate, and 30% fat) for a total of 4 
days (33). On the last day both ghrelin, an appetite stimulating hormone, and GLP-1 were 
measured. They found GLP-1 concentrations were significantly higher in the high protein 
group and ghrelin concentrations were not significantly different between the two groups. 
They also found that the TEF and satiety were significantly higher while hunger was 
lower on the high protein diet.  Despite the energy being essentially equivalent between 
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both meals, data from the respiration chamber revealed subjects were in energy balance 
on the high protein diet but actually registered a positive energy balance on the low 
protein diet.   
 Cholecystokinin (CCK), a peptide hormone which is also found in the 
gastrointestinal tract is another mechanism by which protein can stimulate an increase in 
satiety. Like GLP-1, CCK inhibits gastric emptying but is triggered by the digestion of 
proteins into amino acids, effectively reducing food intake as a result (34).  Testing 
macronutrient effects on CCK and satiety, researchers enrolled a group of both lean and 
obese men to test a series of diets ranging in 4 different macronutrient profiles based 
upon protein levels (HP = 45%, AP = 35%, HF = 15%, and LP = 10%) (35).  After eating 
a standardized breakfast, each group ate lunch from one of the 4 groups which were 
energy balanced. Hormones, hunger, and fullness were continuously monitored for a 
period of 3 hours and energy intake was measured at a buffet meal. The lean group ate 
significantly less from all but the LP (highest carbohydrate) test group. The obese 
individuals who received the HF or LP lunches registered the highest energy intake when 
presented with the buffet. The CCK response to both the HP and AP groups were 
sustained for the duration of time between the lunch and the buffet meals and were 
associated with the greatest levels of satiety.   
 Following a similar design to the previous researchers, Bowen et al., gave liquid 
preloads containing either whey (55g), casein (55g), lactose (56g), or glucose (56g) to a 
group of 19 overweight male participants following a buffet meal 3 hours later. Ghrelin, 
CCK, and satiety were all measured in 15 minute increments after the preload was 
ingested and the participant’s energy intake was analyzed as a quotient of the buffet meal. 
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Energy intake was significantly higher (10 ± 3%; p < 0.05) after the glucose preload 
compared to the other three preloads and this result was predicted by the ghrelin levels (p 
< 0.05) measured at the 120 minute mark after preload ingestion. Higher CCK levels (71 
± 6%; p < 0.05) were measured for both the protein preloads after 90 minutes, and the 
levels at 180 minutes successfully predicted satiety for all 4 groups but had no significant 
link to energy intake. These results suggest that the suppression of ghrelin following the 
protein intake may be related to the satiety reported by participants and appeared to 
interact inversely with CCK levels (36). A recent animal study demonstrated that an 
infusion of CCK had an inhibitory effect on grelin resulting in a reduction in food intake 
(37). 
 Comparing satiety-related hormonal responses following whey and maltodextrin 
intake, a recent study measured GLP-1, CCK, peptide tyrosine-tyrosine (PYY), and 
pancreatic peptide’s (PP) effect on satiety in a group of 18 normal-weight female 
participants (38).  Upon ingestion of either an isoenergetic preload of protein or 
malodextrin (1333 kJ per 300ml versus 1370 kJ per 300ml respectively), the participants’ 
hormone levels and measurements of appetite (hunger, fullness, desire to eat) were 
recorded at regular intervals prior to an ad libitum fried rice test meal. Similar to the 
previous reviewed literature, they confirmed both CCK (60 and 75 min post) and GLP-1 
(90 min post) levels were significantly higher after consuming the protein preload. The 
investigators also noted a significant increase in PYY (90 and 120 min post) and PP (15 
to 120 min post) compared to the maltodextrin intake.  Despite registering increases in 
the satiety-related hormones, only PP had a significant negative relationship (r = -0.21; P 
< 0.01) with energy intake but had no effect on measurements for appetite.  The subjects 
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with the highest plasma PP levels registered the least amount of food intake following the 
preload.  
Amino Acids and Metabolites.  In addition to testing satiety-related hormones, 
Chungchunlam et al., measured plasma amino acids and their relationship to energy 
intake and measurements of appetite (38).  Following the whey protein preload, 
participants’ plasma concentrations of total amino acid, urea, and ammonia were 
significantly higher within 15 minutes compared to the maltodextrin alternative (p < 
0.01).  Despite previous literature (39) suggesting a relationship between circulating 
amino acid concentrations and reduced energy intake, they did not observe relationships 
between plasma amino acids on total energy intake or any measurements of appetite.  
They did however, note a correlation between branched-chain amino acids (BCAA) and 
the rise in both GLP-1(r = 0.26; p < 0.01) and PYY levels (r = 0.48; p = 0.05), suggesting 
a relationship between plasma amino acids and the release of satiety-related hormones.  
Additionally, a negative relationship (r = -0.21; p < 0.01) between urea levels and energy 
intake was noted suggesting a dose-dependent mechanism for satiety with protein intake.  
 Similar to whey protein, plasma amino acids from soy protein sources appeared to 
be correlated to satiety but not total energy intake. Veldhorst et al., gave 25 healthy 
participants energy-adjusted subject-specific breakfast meals categorized as either high 
protein (25% protein, 55% carbohydrate) or normal protein (10% protein, 55% 
carbohydrate) and measured plasma amino acids and satiety at regular intervals for 3 
hours before measuring energy intake with an ad libitum lunch meal (40).  Participants 
with the higher soy protein intake rated as being more satiated and less hungry which 
coincided with an increase in postprandial taurine concentrations (satiety: r = 0.399; P < 
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0.05; hunger: r = 0.433; P < 0.05).  Like the whey protein study, feelings of satiety or 
reduced hunger showed no significant differences on energy intake following soy protein 
intake.  The study also noted a similar increase in urea as Chungchunlam et al., described, 
but was unable to link urea to energy intake.  
 Plasma concentration of amino acids and their metabolites may impact satiety by 
initiating the release of satiety-related hormones but another group of researchers 
suggests amino acids stimulate vagal feedback from the gut to the satiety centers of the 
brain (41). Studying slides of mice hypothalamus and brainstems after a period of 2-
weeks on either a high protein or high fat diet showed that the rats with higher protein 
intake had greater activation of the nucleus tractus solitarius (NTS).  The NTS is a nerve 
bundle in the brain stem which receives both stretch receptors and chemoreceptors from 
the intestinal tract, and receives information from taste buds on the tongue.  The NTS of 
mice on the high fat diet had lowered sensitivity to CCK and a lowered response to serum 
amino acids as a result. The investigators suggested that the feedback to the 
hypothalamus acted to suppress feelings of hunger while stimulation to the NTS affects 
satiety at a reflex-like level. 
 Bypassing the gastrointestinal tract, and thus any possibility for vagal feedback, 
altogether, researchers used parenteral nutrition to test plasma concentrations of amino 
acids on satiety and food intake (42).  Six healthy participants, on three separate 
occasions received in random order an IV saline control, low-dose IVAA (125mg 
protein/kg/h), and a high-dose IVAA (250mg/kg/h) for a total of 360 minutes before 
being presented with a meal. Each subject rated measurements of appetite and satiety at 
30-minute intervals and then their energy intake was recorded after the meal. As 
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expected, feelings of satiety was highest with the high-dose IVAA, followed by the low-
dose IVAA, and finally by the saline solution (p < 0.05). However, feelings of hunger 
were not significantly different between the three groups and as a result the total amount 
of food consumed at the end of the trial was not significantly different. Similar to the 
other studies on amino acids effect on satiety, participants were significantly more 
satiated but total energy intake did not change as a result. The researchers also noted no 
significant correlations between plasma amino acid concentrations or CCK on satiety of 
any of the three groups, seemingly contradicting the findings of other studies measuring 
the same variables. 
Protein-Induced Satiety and Energy Intake 
Research into the mechanisms of protein-induced satiety demonstrated a number 
of factors on how protein intake is correlated with satiety, but many failed to define a 
significant link between those factors and an overall reduction in energy intake. Moving 
beyond the mechanisms of protein on satiety and focusing on the effects of the system as 
a whole may help to demonstrate a significant link between protein-induced satiety and a 
reduction in energy intake.  Weigle et al., designed a food trial using subject-specific 
weight-maintaining prepared meals (30% protein, 20% fat, and 50% carbohydrate) to 
increase participants’ protein intake from baseline levels (15% protein, 35% fat, and 50% 
carbohydrate) over a period of 2 weeks before transitioning them to an ad libitum diet 
using the same prepared meals for the following 12 weeks (43). After at least a week on 
the high protein isocaloric diet, participants reported an increase in fullness and a 
decrease in hunger which coincided with a reduction in caloric intake (494 ± 74 kcal/d) 
within 24 hours of starting the ad libitum portion of the trial. The participants maintained 
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a significant reduction in caloric intake (441 ± 63 kcal/d, p < 0.001) for the duration of 
the trial despite reported measures of appetite returning to baseline levels within a week 
of the transition.  In an interesting twist, in this study, satiety regressed to the original 
mean while energy intake levels continued to be lower for a duration of approximately 12 
weeks after switching to a high protein diet.   
Similar results were noted by Latner et al., after measuring ad libitum intake at 
dinner by participants by comparing the satiating effects of three 450kcal liquid lunches 
composed of a mixture of proteins and carbohydrates (protein = 71.5% of energy, 
carbohydrate = 99% of energy, or 35.7% protein and 55.1% carbohydrate) (44).  The 
participant group with the highest protein lunch ate 31% less (~300 kcal) calories than the 
carbohydrate group, and 20% (~90 kcal) less that the moderate protein group. 
Participants in the high carbohydrate group reported significantly higher hunger before 
dinner and reported greater satisfaction after eating than the other two groups. Using 
similarly disproportionate protein levels (81% versus 14% of energy) in their study, 
Johnson et al., showed participants reported higher satiety and ate a significantly smaller 
energy intake after the protein preload (45).  However, they assessed sensory-specific 
satiety played a larger role than macronutrient composition on energy intake.  
The reduced sensory appeal of the high levels of protein in the preload was one 
factor for the reduction in calorie intake, highlighting that the reduction in calories 
reported was at least partly a coefficient of participant dissatisfaction (45). However, 
MacKenzie-Shalders et al., demonstrated diminishing returns on satiety and energy intake 
as protein intake increases (46). Testing a whey protein supplement (20g, 40g, 60g, or 
80g protein) on 10 male athletes, they found all men reported significantly lower ratings 
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of hunger (50% to65%, p < 0.05) for the duration of the 3 hours between taking the 
supplement and eating an ad libitum meal. Regardless of their appetite sensations, each 
participant’s energy intake from the meal was not significantly different from one 
another, representing about 30% of their estimated energy requirement. An increase 
above 20 grams of whey protein presented no beneficial impact in lowering food intake 
or increasing satiety despite nearly a 1000 kJ increase in energy consumed in the highest 
protein supplement compared with the lowest protein supplement.  Another group of 
researchers determined that whey protein doses above 10g had a significant impact on 
reducing food intake, but comparatively no increase in benefit was detected between 10g, 
20g, 30g, and 40g conditions (47).   
Protein and Weight Loss 
 Higher amounts of protein intake above DGA levels have been demonstrated to 
have a positive relationship on the increase of satiety and other measures of appetite.  The 
suppression of appetite in response to protein has a negative relationship with energy 
intake and that relationship may be dose-dependent. A number of studies and trials have 
been conducted to determine if protein-induced satiety and its relation to energy intake 
would result in reduction in total body weight.  Evaluating studies focusing on total 
weight loss, body composition, and the safety of high-protein diets are necessary to 
understand the efficacy of increasing daily intake of protein.    
Short Term Weight Loss.  Soenen et al., created an energy-restricted 2 x 2 
factorial weight loss trial (132 participants) over a period of 3 months (energy intake = 
33% of energy requirements) followed by a 9 month period designed for weight 
maintenance (energy intake = 67% of energy requirements). The macronutrient 
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composition (protein/carbohydrate/fat) and labels of the 4 diets is as follows: HPLC – 
20/25/55, HPNC – 20/50/30, NPLC – 10/25/65, and NPNC – 10/50/40.  After 3 months, 
the both HP groups lost significant amount of weight (-14.1 ± 4kg; p < 0.001) and fat 
mass (-11.9 ± 1.7kg; p < 0.001) independent of carbohydrate intake. The same held true 
for the NP groups in regards to both weight loss (-11.5 ± 4kg; p < 0.001) and fat mass (-
9.3 ± 0.7kg; p < 0.00s).  No significantly relevant difference was noted between the 
change in weight loss and fat mass between the 2 protein groups. A similar trend was 
noted at the 12 month mark with both the HP and NP groups maintaining significant 
weight loss independent of carbohydrate intake. The authors of the study concluded that 
weight loss and weight maintenance were dependent on the high protein aspect of the diet 
but not the low carbohydrate component independent of fat content (48).  Unfortunately, 
they did not measure satiety or any measure of appetite between the 4 test groups to 
determine participant comfort during the trial.   
 Johnston et al. both confirmed the successful impact of a high-protein diet for 
weight loss independent of the carbohydrate component and an increase of reported 
satiety and satisfaction by the participants after a pair of food trials over a period of 6 
weeks. Maintaining the same protein content (~30% of energy) between both test groups, 
they compared the results of a ketogenic low-carbohydrate (KLC) test diet (~5% energy 
carbohydrate) with a nonketogenic low-carbohydrate (NLC) diet (~40% energy 
carbohydrate) to determine the role carbohydrates play in a high-protein dietary approach 
(49).  After 6 weeks, participants in both groups had similar success with weight loss 
(KLC = 6.3 ± 0.6 kg, NLC = 7.2 ± 0.8 kg) but a diet-specific weight loss advantage was 
not noted.  Participants in both groups reported an overall improvement in hunger ratings 
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(No particular feeling to satisfied) but no significance on this measure of satiety was 
reported between the two test meals. In a separate weight loss food trial, they compared 
an isocaloric high-protein, low-fat (HPLF) diet (protein = 30% of energy, fat < 30%) with 
a high-carbohydrate, low-fat (HCLF) diet (carbohydrate = 60% of energy, fat < 30%) to 
determine successful outcomes (50).  After the 6-week intervention, participants in both 
groups were equally successful in reducing both body weight (HPLF = -5.7 ± 0.6%, 
HCLF = -5.9 ± 0.5%) and fat mass (HPLF = -8.9 ± 2.2%, HCLF = -10.6 ± 1.4%) with no 
significance reported between the two test groups. Participants in the HPLF group 
reported greater diet satisfaction during the first 4 weeks of the trial but the data did not 
reach the significance threshold. 
 Analyzing perceived hunger and weight loss when comparing low-carbohydrate, 
high-protein (LCHP) diets with high-carbohydrate, low-fat diets (HCLF), Nickols-
Richardson et al., created a 6 week food trial to determine if either diet was statistically 
superior (51). Overweight premenopausal women were recruited for the study received 
instructions on calorie restricted diets ( 1,500 – 1,700 kcal/d) and were separated into two 
groups including either LCHP (carbohydrates < 40g/d, protein was unrestricted) or HCLF 
(60% energy from carbohydrate, 15% protein, and 25% fat) diets. At the end of the trial, 
the women on the LCHP diet lost significantly (p < 0.05) more weight (5.7%) compared 
to the HCLF diet (3.3%), but both groups had a significant (p < 0.0001) reduction in BMI 
which did not differ between the two groups. In addition, participants in the LCHP diet 
reported a significant score reduction (p < 0.03) in perceptions of hunger after the trial 
(3.2 ± 2.4) compared to their baseline scores (6.3 ± 4.1) whereas the HCLF did not. 
However, they noted the estimated average daily energy intake was not significantly 
  22 
different between the two groups despite the differences reported in perceptions of 
hunger.  Perceptions of hunger, independent from energy intake, is recognized as an 
important factor which impacts body weight regulation, body composition, and success 
with weight loss goals, suggesting the reduction in hunger felt by the LCHP diet plays an 
important role in healthy outcomes of a weight loss intervention (52).   
 Over a 12-week period following a structured plan, hypo-caloric diets composed 
with a high-protein (HP = 27% energy from protein, 44% carbohydrate, 29% fat) 
component was compared with a standard-protein (SP = 16% energy from protein, 57% 
carbohydrate, 27% fat) diet to determine outcomes on total weight loss, total fat loss, and 
reductions in abdominal fat (53). At the end of the trial both weight loss (HP = 7.82 ± 
0.37 kg; SP = 7.65 ± 0.39 kg) and total fat loss (HP = 6.8 ± 4.3 kg; SP = 6.4 ± 4.7 kg) 
between the two groups were not significant but effective nonetheless.  However, 
participants in the HP group with the highest level (>1.54 mmol/L at baseline) of 
triglycerides (TAG) lost significantly more weight (p = 0.01), total fat (p = 0.007), and 
abdominal fat (p = 0.005) compared to the SP group with similarly elevated TAG levels. 
The results suggest high-protein diets may be particularly effective for individuals with 
elevated TAG levels, a common condition within obese populations, when compared to 
other weight loss regimens.   
 Testing high-protein intake within morbidly obese populations may highlight the 
importance between the relationship of extremely elevated TAG levels and the 
effectiveness of short-term high-protein diets.  Triffoni-Melo et al., separated a group of 
19 class III morbidly obese women into two experimental groups receiving a 1,200 kcal 
diet for a total of 8 days (54). The control group received a diet with an energy intake 
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macronutrient profile containing 171g (54%) carbohydrate, 74g (23%) protein, and 32g 
(23%) of fat while the experimental group received 45g (15%) carbohydrate, 105g (35%) 
protein, and 67g (50%) fat.  At the end of the trial, the experimental group realized a 
significantly (p = 0.01) larger weight loss (4.4 kg) when compared to the control group 
(2.6 kg).  In addition to the lost weight, the TAG levels in the experimental group from 
day 1 to day 8 was statistically lower within the group (-44.3, p < 0.05) when compared 
to the control group which did not see any significant change during this time. However, 
no significance was noted between the two groups relevant to changes in TAG.  This may 
be related to the fact that TAG levels at baseline approached significant differences (p = 
0.09) between the experimental and control groups (161.2 ± 70.0 mg/dl vs. 124.6 ± 46.7 
respectively).  
 A number of studies have shown that high-protein diets are at least as effective as 
other weight loss strategies and increased protein intake in terms of short-term dieting 
may be more beneficial in certain populations.  In addition to short-term weight loss, 
high-protein diets may also prove to be more beneficial when looking at weight loss 
maintenance. Following a 6 week period of energy restricted dieting, a group of 48 
participants were placed on a low-fat diet for a period of 12 weeks and received either a 
maltodextrin (HC), casein (HP-C), or whey (HP-W) supplement (2 x 25g/d) for the 
duration of the trial.  The participants taking either of the HP supplements had 
significantly better weight maintenance (-2.3kg, p = 0.04) and maintained lower fat mass 
(-2.2kg, p = 0.02) when compared to the HC group. No statistical advantages were noted 
between the whey and casein supplement regarding weight maintenance and biomarkers 
from all three supplements were not significantly different (55).  
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Long-term Weight Loss.  Dalle Grave et al., conducted a randomized trial over a 
period of 52 weeks to determine weight loss on energy-restricted high-protein versus 
high-carbohydrate diets within a morbidly obese population (56). After 3 weeks of 
inpatient treatment, a total of 88 participants continued the remaining 48 weeks of their 
assigned weight loss treatment (1200 kcal/d for women, 1500 kcal/d for men) in an 
outpatient setting. The participants were randomly assigned into either a high-protein 
group (HPD = 34% energy from protein, 20% fat, 46% carbohydrate) or a high-
carbohydrate group (HCD = 17% energy from protein, 20% fat, 64% carbohydrate). 
After 1 year, the HPD group lost an average of 15% body weight and the HCD lost about 
13.3% but no significant difference was noted between the two groups.  Interestingly, the 
attrition rates were statistically similar between groups which might be explained by the 
possibility that the outpatient nature of the trial reinforced participant adherence by 
providing a form of social support and structure. The unintentional compliance 
reinforcement may explain the similar level of weight loss experienced. Unfortunately no 
measures of body composition were recorded during the trial to allow for comparisons 
between the two groups.  
 Over a period of 6 months, Skov et al., compared weight loss and body 
composition between the administration of both high-carbohydrate (HC) and high-protein 
(HP) diets in overweight and obese participants (57).  The HP diet energy composition 
consisted of 25% protein and 45% carbohydrate while the HC diet contained 12% protein 
and 58% carbohydrate with fat being held constant at 30% between the two diet plans.  
After 3 months, the HP group lost a significantly (p < 0.02) greater amount of average 
weight (-7.5 kg) compared to the HC group (-5.0 kg) and the weight loss was composed 
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of significantly more fat respectively (-5.8 kg vs. -3.8 kg, p < 0.02).  Additionally, at the 
3 month mark, more participants from the HP group had lost over 5 kg body weight 
compared to the HC group (79% vs. 52%, p < 0.05). A similar trend was reported 
between the two groups at the end of the 6 month trial. The HP group averaged more 
weight loss than the HC group (8.7 kg vs. 5.0 kg; p = 0.0002) and a greater percentage of 
weight loss was from fat (7.6 kg vs. 4.3 kg; p < 0.0001).  More participants lost over 10 
kg on the HP diet than the HC diet as well (35% vs. 9%; p < 0.001).  Overall, a higher 
percentage of participants on the HP diet realized clinically relevant weight loss and this 
was exemplified by comparison in the reduction of intra-abdominal adipose tissue 
between the two groups (HP = -33 cm², HC = -16.8cm²; p < 0.0001). The researchers 
credit the increase in weight loss of the HP group over the HC group to the satiating 
effect of protein as participants in the HP group reported significantly lower energy 
intake than the HC group (2 MJ lower intake; p <0.001) which is consistent with prior 
research (58).  
 Weight loss on a high-protein diet has been shown to be quite effective over a 
period of up to 6 months, but once the time frame is extended up to 12 months the results 
appear to be less clear.  Foster et al, enrolled 63 obese participants into a one year food 
trial comparing the effects of weight loss from either a low-carbohydrate, high-protein 
(HP) diet or a conventional low-calorie, high-carbohydrate (HC) diet (59). Similar to 
Skov et al., they found that participants in the HP group lost significantly more weight 
than the HC group at both the 3-month (-6.8 ± 5.0% vs. -2.7 ± 3.7%; p =0.001) and 6-
month mark (-7.0 ± 6.5% vs. -3.2 ± 5.6%; p = 0.02).  After 12 months however, no 
significant difference was found between the two groups (-4.4 ± 6.7 vs. -2.5 ± 6.3%; p 
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=0.26). Due to the hands off approach by the researchers, attrition rates were high in both 
groups which may help to explain the failure to find significant differences between the 
two groups at the end of the trial. A total of 85% of participants completed 6 months of 
the trial but only 59% completed the full 12 months. Measures for body composition 
were not recorded so no comparison between the clinical significance of the weight loss 
could be assessed.  
 Wycherley et al., designed a year long food trial to determine the long-term 
effects a high-protein diet had on not only weight loss, but body composition (60). A total 
of 120 obese men were put on a low-fat (25% total energy), energy-restricted isocaloric 
diet composed of either high protein (HP = 35% energy protein and 40% carbohydrate) or 
high carbohydrates (HC = 17% protein, 58% carbohydrate).  Of the 68 participants who 
finished the trial, all of them had statistically similar reductions in total weight and fat 
mass.  The HP group did however have a significant reduction in percent body fat mass at 
week 12 (-5.0 ± 3.3% vs -3.1 ± 3.7; p < 0.01) compared to the HC group as it related to a 
significant reduction in percent loss of total body fat free mass (FFM) at week 52 (-2.6 ± 
3.7 vs. -3.8 ± 4.7; p < 0.05). The reduced loss of the metabolically active FFM in the HP 
group is important to long-term weight loss maintenance as diets below protein 
requirements (based upon nitrogen balance) increase the risk of body weight regain (62).  
Even though the HP group did not lose more weight over the duration of the trial, the 
weight loss is clinically more significant. 
 Evaluating weight maintenance over a period of 6 months, Larsen et al., enrolled 
more than 900 participants who had recently lost at least 8% of their total weight loss into 
a food trial to determine the effects of protein and glycemic load on body composition 
  27 
(62).  In a 2-by-2 factorial design, they essentially created 4 diets including high-protein, 
high-glycemic index (HPHG), low-protein, high glycemic index (LPHG), low-protein, 
high glycemic index (LPHG), and low-protein, low glycemic index (LPLG). The high-
protein diets equated to a total energy value of 25% of calories from protein and the low-
protein diet had a total of 13%. No restrictions were placed on energy intake, but they 
targeted at least a difference of 15 glycemic index points between the high and low diets. 
Attrition rates in the HP groups and the LG groups were significantly lower than those of 
the LPHG group (26.4% and 25.6% vs. 37.4%; p = 0.02 and p =0.01).  In addition to the 
highest attrition rate in the study, the LPHG group was the only one of the four to gain a 
significant amount of weight back by the end of the trial (1.67 kg {0.48 to 2.87}, p = 
0.05). The HP groups, regardless of glycemic index, gained less weight (0.95 kg, p = 
0.05) back compared with the LP groups. No other significant data regarding body 
composition was reported.  In conclusion, they suggested that high-protein diets with 
lower glycemic indexes may prove to be an ideal for weight loss maintenance.  
Safety and efficacy.   
 Evaluating the efficacy and safety of high-protein diets, Krebs et al., divided 
participants into a high-protein, low-carbohydrate (HPLC = 2-2.5g/kg of protein/body 
weight) group or a low fat LF = 30% of energy) group for a period of 13 weeks where 
they here heavily monitored for safety (63).  Both test groups resulted in significant 
weight loss for both groups but not between groups.  The HPLC actually resulted in a 
slight but significant average loss of FFM (p = 0.05) where the LF diet did not, 
contradicting a number of other trials focused on high-protein diets.  At the end of the 
trial DEXA measurements were taken and neither group had significant changes in bone 
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mineral density.  Both diet regimens resulted in improvements in several biomarkers 
including significant reductions in both total and LDL cholesterol levels.  Triglyceride 
levels were significantly (p = 0.0003) reduced (approximately 3 times more) in the HPLC 
group compared with the LF diet (between groups, p = 0.03). Both fasting glucose and 2-
hour glucose did not differ between the two diets. Participants on the HPLC diet showed 
no adverse affects to the diet and biochemical indices like BUN, liver function tests, 
creatinine, and other serum chemistries came back WNL. The only significant issues 
reported with the high-protein diet compared with the low-fat diet during the trial was 
complaints of headache (p = 0.04).  The researchers were a little surprised by the 
reduction of FFM within the HPLC group, but they concluded that the diet was both 
effective and safe for weight loss in obese populations.   
 Individuals eating ad libitum with short-term high-protein diets have been shown 
to lose an average of about 1 kg per week (64). Over the course of 12 months, high-
protein diets resulted in less clear results compared to high-carbohydrate diets.  Weight 
loss associated with protein usually results in a reduction in FFM and an increase in the 
maintenance of lean mass as part of a calorie-restricted diet, related to the composition of 
protein in the diet (65).  A recent meta- regression examined high-protein intake as part 
of a short-term diet approach indicating that 1.05 g protein/kg of actual body weight 
resulted in protein sparing nearly 0.6 kg over a period of 6 weeks and 1.2 kg over a 
period of 12 weeks (66). The efficacy of weight loss with high-protein diets appears to be 
greater with short-term diets but more studies need to be completed to determine whether 
or not high-protein diets are warranted for long-term weight loss goals.  
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 While high-protein diets are efficacious for weight loss, the DGA recommends 
lower amounts as part of a healthy diet citing worries about bone and kidney health with 
prolonged elevated protein intake. The recommendations of the DGA highlight safety 
concerns but the question is whether or not these concerns are warranted.  Protein plays a 
vital role in bone collagen synthesis but increased protein intake has been linked to the 
promotion of increased excretion of calcium in the urine (67).  The increase in calcium 
excretion has been linked to the argument that high-protein intake is linked to a negative 
impact on bone health and osteoporosis.  The American Journal of Clinical Nutrition 
reported that dietary protein in fact seems to play a positive role in bone health and stated 
that at the very least protein in not detrimental (68).  A related systematic review on 
dietary protein and bone health reported a beneficial influence of protein supplementation 
on bone mineral density (as protein intake increases calcium absorption from the diet), 
but noted the significant positive effects came from meat protein and not vegetable or 
dairy proteins (69).  While urinary calcium may increase as a result of protein intake, it 
does not appear to be relevant to bone health suggesting high-protein diets are safe 
regarding calcium in the body.  
 The focus on urinary calcium excretion brings attention to another concern 
circulating around high protein diets; the effect on renal function and health.  Frank et al., 
stated high-protein intake can lead to glomerular hyperfiltration, proteinuria, diuresis, and 
increased risk for nephrolithiasis under certain conditions and can exacerbate chronic 
kidney disease (70).  High protein diets, especially considering short-term durations, raise 
questions about whether increased protein intake within healthy populations has any 
negative impact on normal kidney function. A review of both epidemiologic and 
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experimental data on the safety of protein and kidney health concluded little evidence 
exists to suggest high-protein diets are dangerous or have adverse effects in individuals 
with normal renal function (71).  A study focusing on trained athletes suggests protein 
intake of up to 2.8 g/kg of body weight showed no negative effects on kidney health. 
(72).  However, a separate study has suggested that intakes higher than this amount could 
significantly increase risk for developing both kidney and uric acid stones (73).  None of 
the weight loss diets reviewed had intakes anywhere close to these levels suggesting 
high-protein diets for weight loss are safe in relation to kidney health without the 
presence of established renal diseases. 
 Despite promising research promoting the safety and efficacy of high-protein 
diets, Hernandez-Alonso et al., found that chronic high-protein intake is associated with 
increased body weight and total death risk (74). They analyzed the PREDIMED trial 
focusing on dietary protein levels reported on food-frequency questionnaires.  They 
found that as protein intake increased as percentage of energy, the risk for weight gain 
(HR: 1.9; p = 0.05) rose significantly when it replace carbohydrates in the diet but not fat. 
Additionally, they found that increased protein intake was also linked to greater risk for 
all-cause death when it was substitute for both carbohydrates (HR: 1.59; p = 0.05) and fat 
(HR: 1.66; p = 0.05).  The study reports the results were related to only long-term high-
protein intake and was only associated with animal protein.  The increase mortality risk 
may be associated with another study as Sandhu et al., found that an increased intake of 
all meat or red meat of at least 100 g/d was associated with a 12-17% increase risk of 
colorectal cancer (75).  None of the weight loss studies reviewed sustained protein intake 
long enough to be significantly implicated in the risk for increased mortality. 
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Studies Related to the Zone Diet 
 High-protein, lower-carbohydrate diets have been shown to be both effective and 
safe for weight loss but studies focusing on popular diets with similar macronutrient 
profiles are scarce.  Most people who make a diet attempt are going to choose a name 
brand diet emphasizing the need to address the health effects of popular diets.  Dansinger 
et al., compared 4 popular diets representing different macronutrient profiles to determine 
the effectiveness on weight loss (76).  Participants were assigned diets including Atkins 
(restricted carbohydrate), Zone (Balanced macronutrient profile), Weight Watchers 
(restricted calories), or Ornish (restricted fat) for a period of 12 months. They were 
instructed to maintain strict adherence to the diets for 2 months before being permitted to 
maintain the diet ad libitum for the remainder of the trial.  Weight loss between the diet 
groups was not found to be significant but the amount of weight loss was correlated to the 
reported adherence levels (r = 0.60; p < 0.001) essentially meaning the participants who 
followed the diets lost the most weight. A total of 53% of participants finished the trial on 
the Atkins diet while 65% completed with both the Zone and Weight Watchers, and only 
50% completed the stricter Ornish diet. Despite the difference in completion rates, no 
significance was noted between the four groups.  However, participants finishing in the 
top ranking for adherence, independent from diet type, lost an average of 7% of their 
initial body weight suggesting diet compliance was an important factor in this study. All 
groups realized a mean reduction in total caloric intake for the duration of the trial but no 
diet was significantly better that the other.  
 Following a very similar study design, Gardner et al., was able to find a 
significant advantage of one diet over the other three (77).  They randomly assigned 311 
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overweight and obese premenopausal women into one of four diets to determine 
outcomes on weight loss: Atkins, Zone, Ornish, and LEARN. Similar to the previous 
study, the participants were instructed to put in maximum effort for the first 2 months and 
then were on their own for the remaining 10 months of the trial.  At the end of the trial 
they noted the participants in the Atkins group had significantly greater amount of weight 
loss (Atkins = -4.7 ± 1.6 kg, Zone = - 1.6 ± 1.2 kg; p = 0.05) when compared to the Zone 
group but not the other two diets. In fact, the other 3 diets all resulted in weight loss but 
not significant between the groups. The Atkins faired significantly better than all the diets 
at months 2 and 6 of the trial (p = 0.05 for both).  Dietary retention for all 4 groups was 
similar but diet adherence was not measured or statistically analyzed by the researchers.  
The previous study comparing a similar spectrum of diets controlled for participant 
adherence, noting the weight loss was significantly correlated to the level of adherence. 
Considering both studies followed a nearly identical design, the significance of the 
weight loss may be skewed towards adherence levels compared to diet effectiveness. 
Clearly more research needs to be completed to determine the health effects of these 
popular diets.  
 
 
 
 
 
 
 
  33 
Chapter 3 
METHODS 
Participants  
The primary inclusions for the study were healthy adults between the ages of 20 
and 75 with a BMI between 25 and 42kg/m².  Participants were screened for chronic 
conditions, food allergies and diet restrictions, and advised on the use of pasta and cereal 
as the primary portion of their diet through the duration of the trial. Exclusion criteria 
included the use of insulin and cigarettes, plans to change diet and/or physical activity 
levels during the duration of the trial, and/ or weight change greater than +/- 10 pounds 
within three months of the study. In addition to these factors, pregnant or lactating 
women or women who have given birth within the prior six months were excluded from 
the study. Prescription medication use was permitted so long as the use had been 
consistent for at least three months and would remain consistent for the duration of the 
trial.  Participants were required to have access to a refrigerator which was necessary to 
safely store the test foods.  
Participants were recruited through the Arizona State University community via 
electronic messaging, posted flyers, and word of mouth. All interested individuals were 
instructed to complete the online eligibility survey to determine if they qualified for the 
study. Those individuals who were eligible to partake in the study were invited to the 
nutrition laboratory at the ASU downtown campus to discuss the food trial in detail. 
Upon signing the informed consent for the study (Appendix B), the participants 
completed a health history questionnaire (Appendix C) and set up a time to collect a 
fasting blood sample to determine the ratio of triglyceride to cholesterol levels 
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(TG/HDL).  Recruiting ceased once a total of 45 participants met the inclusion criteria 
and were enrolled into the study. 
Study Design 
 Before the study began, the 45 participants were instructed on how to follow a 
weight loss diet while incorporating the trial foods (Appendix D). They completed a 3-
day diet record at the start of the trial and recorded their diet daily during the 12 week 
trial in a spiral notebook.  During their initial visit, the participants scheduled a weekly 
time and date to receive their prepared meals for the duration of the study. The 7-day 
rotating menu consisted of breakfast cereal, a pasta meal for lunch (fusilli-based) and for 
dinner (orzo-based).  These meals were prepared, portioned, and frozen weekly in the 
Arizona State University metabolic kitchen. A total of 7 cereal packets and 14 pasta 
meals were prepared weekly for each participant. The test meals included pasta and 
cereal developed using patented food technologies from the Zone Diet, Inc. The control 
dishes were produced using commercially available gluten-free rice pasta and a 
conventional name brand boxed cereal.   
The ingredients and nutritional information are shown in Table 1 for both the 
experimental and control meals.  The average macronutrient breakdown for calories, 
percent energy intake, and weight provided by the test meals are shown in Table 2. The 
participants were provided with food packages each week to be consumed the following 
week for the duration of the 12-week trial. Following a blinded crossover design, 
participants received the respective test and control meals for each six week segment of 
the trial.  As the test meals only provided an average of 950 kcal/d, all participants 
received diet counseling on foods to consume in addition to the test foods to keep to a 
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calorie total that would permit modest weight loss weekly (approximately 1 pound per 
week: see Appendix D).  Participants received information pertaining to their specific 
caloric intake needs along with recommended foods to consume to meet those needs in 
addition to the test meals. Participants were able to eat additional foods ad libitum and 
received no further instruction on food intake during the trial.  
 The participants’ height was measured at the beginning of the trial and their 
weight was measured weekly when they received their food packages using a spring scale 
(Health o meter Doctor’s scale, Neosha, MO). Waist and hip circumferences and body 
composition using bioelectrical impedance technology (Tanita scale, Arlington Heights, 
IL) and DEXA (at weeks 6 and 12 only) were taken along with a fasting venous blood 
sample at trial weeks 0, 6, and 12. (Apart from the calculation of the TG/HDL ratio 
which was used as an inclusion criteria, blood analyses were not further analyzed for this 
report. Also, data are only reported for the first 6 week phase of the 12-week trial.)  
Participants were instructed to avoid moderate to intensive exercise at least a day prior to 
taking these measurements at weeks 0, 6, and 12 to improve accuracy. In addition to 
these measures, participants recorded their adherence and compliance to their respective 
diet on a calendar. These records included whether or not they ate each of the three food 
items per day and were the only measure of adherence reported. Additional foods were 
reported in their spiral notebook as part of their food diary but were used solely to 
calculate energy intake and were not used to measure adherence.  No tool to measure 
satiety was implemented during the trial.  Energy intake was calculated by scoring the 
most complete daily diet record each week to estimate the intake for the entire week 
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during the first half of the study.  Physical activity questionnaires (Appendix E) were 
completed at 3-week intervals to assess any influence on the weight loss program.  
 
Table 1.  Nutrition Facts for Test Meals 
Test Pasta and Cereal 
 Zone PastaRX - Orzo Zone PastaRX - Fusilli           Zone Cereal  
Serving Size: 1 Cup (60g) Serving Size: 1 Cup (60g) Serving Size: 1 Cup (60g) 
  
Amount 
Per 
Serving   
Amount Per 
Serving   
Amount Per 
Serving 
Calories 240 Calories 240 Calories 240 
Fat 4g Fat 4g Fat 10.5g 
Carbohydrate 28g Carbohydrate 28g Carbohydrate 24g 
Protein 20g Protein 20g Protein 21g 
 
Control Pasta and Cereal 
    Gluten Free- Orzo    Gluten Free - Fusilli        Control Cereal  
Serving Size: 2 oz (58g) Serving Size:  2 oz (58g) Serving Size: 1 Cup (60g) 
  
Amount 
Per 
Serving   
Amount Per 
Serving   
Amount Per 
Serving 
Calories 200 Calories 200 Calories 260 
Fat 1.5g Fat 1.5g Fat 5g 
Carbohydrate 44g Carbohydrate 44g Carbohydrate 52g 
Protein 3g Protein 3g Protein 4g 
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Table 2.  Prepared Food Profiles:  Average total calories, percent energy intake, 
and weight of macronutrients provided by Zone and control diet test meals.¹ 
 
Zone Diet: Orzo Pasta 
(364 kcal provided) 
 
Control Diet: Orzo Pasta 
(324 kcal provided) 
 
Energy Intake 
(%) 
Weight  
(g) 
 
Energy Intake 
(kcal) 
Weight 
(g) 
Protein 26 24.7  8 10.5 
Fat 28 11.5  25 9.4 
Carbohydrate 43 39.1  68 52.7 
Fiber - 6.0  - 5.2 
Total Energy 98 -  101 - 
 
 
Zone Diet: Fusilli Pasta 
(358 kcal provided) 
 
Control Diet: Fusilli Pasta 
(324 kcal provided) 
Protein 28 23.9  13 6.9 
Fat 29 11.4  26 8.9 
Carbohydrate 44 39.2  65 55.2 
Fiber - 4.5  - 3.5 
Total Energy 100 -  104 - 
 
 
Zone Diet: Cereal 
(240 kcal provided) 
 
Control Diet: Cereal 
(260 kcal provided) 
Protein 35 21  6 4 
Fat 39 10.5  19 5 
Carbohydrate 40 24  80 52 
Fiber - 5  - 2 
Total Energy 114 -  105 - 
 
 
Zone Diet: Totals² 
(962 kcal provided) 
 
Control Diet: Totals³ 
(908 kcal provided) 
Protein 29 69.5  9 21.4 
Fat 31 33.4  22 23.3 
Carbohydrate 43 102.4  66 159.9 
Fiber - 15.5  - 10.7 
Total Energy 103 -  98 - 
¹Data in table represent averages provided by the recipes in appendix F. 
²Zone diet recommended macronutrient profile percentages are 30/40/30 
(protein/carbohydrate/fat) 
³DGA recommended macronutrient profile percentages are 10-15/45-65/20-35 
(protein/carbohydrate/fat) 
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Study Timeline 
    
Variables  
All anthropometric measurements were taken using the same equipment 
calibrated prior to the start of the feeding trial. All weight measurements were gathered at 
roughly the same time every week for each participant and recorded in a coded chart 
which was uploaded into a spreadsheet at the conclusion of the study. The average of 
three waist and hip circumference measurements were recorded at the respective 
timeframes within the study and then recorded by the same individual to reduce variance 
within each measure. Diet records and calendars were used to determine compliance with 
Screening Visits 
    (Nov/Dec) 
Study Weeks 
(Jan/Feb/Mar/Apr) 
1 2 3 4 5 6 7 8 9 10 11 12 C 
R 
O 
S 
S 
O 
V 
E 
R 
REC (n=23) 
CON (n=22) 
CON  
REC 
 
Randomized 
To Groups 
Visit 1 
Screening 
 Informed 
Consent 
 Health History 
 Anthropometric 
Measurements 
 Mood 
Questionnaire 
 Physical Activity 
 Fasting Blood 
Sample 
 Diet Record 
Instruction 
 Enrollment 
Visit 2 
Baseline 
 
 Food Pick-up 
 Anthropometric 
Measurements 
 Mood 
Questionnaire 
 Physical Activity 
 Fasting Blood 
Sample 
 Diet Record 
Collection 
 
Visit 3-6 
Weeks 2-5 
 
 Food Pick-up 
 Weight 
Measurements 
 Diet Record 
Collection 
 
Visit 7 
Crossover 
 Food Pick-up 
(switch) 
 Anthropometric 
Measurements 
 Mood 
Questionnaire 
 Physical Activity 
 Fasting Blood 
Sample 
 Diet Record 
Collection 
 
Visit 8-12 
Weeks 7-11 
 Food Pick-up 
 Weight 
Measurements 
 Diet Record 
Collection 
 
Visit 13 
Study End 
 Anthropometric 
measurements 
 Mood 
Questionnaire 
 Physical Activity 
 Fasting Blood 
Sample 
 Diet Record 
Collection 
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the prepared meals and calculate additional calories provided by other foods consumed 
during the trial. Fasting venous blood samples were collected by the same research nurse 
at the nutrition laboratories at the Arizona State University downtown Phoenix campus 
and analyzed to calculate the participant’s TG and HDL levels.  
The combination of weight, body composition, and waist and hip circumferences 
provided a detailed summary of fat loss or gain throughout the duration of the 12-week 
study. For the primary hypotheses to hold true the expectation would be for the test group 
to realize a reduction in total body weight with a greater percentage of loss from fat and 
not lean body tissues. Determining the composition of any weight lost provided evidence 
on the effectiveness of the feeding trial at lowering body weight.  A fasting blood sample 
was employed to qualify participants for the study based upon elevated triglyceride and 
cholesterol levels. An elevated TG/HDL ratio is strongly related to overweight status and 
is regarded as a reliable indicator for metabolic syndrome and heart health.  Enrollment 
into the study required an elevated TG/HDL ratio, however, blood data was not presented 
for this report. Finally, the use of physical activity questionnaires at scheduled intervals 
helped to identify possible influences within the study outcome.  
Laboratory Analysis 
Blood indices were measured from intravenous blood samples drawn after a 12-
hour fast. The blood draws were initially used to measure TG and cholesterol levels and 
calculate a TG/HDL ratio to identify exclusion criteria and set baseline measures.  
Inclusion factors considered for the study included TG/HDL levels within the top half of 
the ratios of all who were tested.  Fasting venous blood draws were collected at weeks 0, 
6, and 12 were used to calculate the change from baseline to the end of each six week 
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crossover period. The same laboratory researcher took every blood sample and calculated 
the TG/HDL ratio to reduce potential for bias. A standard lipid panel was utilized to 
calculate TG and cholesterol levels and the TG/HDL was calculated based upon the 
results.  
Statistical Analysis 
Statistical calculations were completed using SPSS Statistical Analysis software 
version 19.  All variables were controlled for gender to account for the gender differences 
in body mass and composition.  Data were normally distributed and analyzed by 
independent t-test and univariate analysis of variance.  Data is reported as means ± 
standard error (SE) unless indicated differently.  Variables were considered significantly 
different at p ≤ 0.05. Participant energy intake was calculated by using the best daily diet 
record entry each week as an estimate for the entire week.  Food Processor SQL was used 
to calculate calorie intake from food records. Weekly activity was quantified 
(kcal·kg−1·wk−1) from survey data measuring duration and frequency of energy 
expenditure sessions per week. 
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Chapter 4 
DATA & RESULTS 
 A total of 41 people were enrolled to participate in the food trial and following 
stratification by BMI, age, and gender they were randomly assigned into either the Zone 
group (n = 21) or the control group (n = 20). Prior to the start of the trial, one individual 
withdrew for personal reasons (control group).  Of the 40 remaining participants that 
initiated the trial, 18 withdrew before week-6 due to schedule conflicts, dissatisfaction 
with the test meals, or other personal reasons.  A total of 11 participants in each of the 
test groups finished the 6-week parallel-arm trial and were assessed for data analysis. One 
participant in the Zone group was not measured for FFM at baseline.  In addition, 6 
participants in the Zone group and 5 participants in the control group did not turn in food 
records at the end of the trial and were not assessed as part of change in energy intake.  
 Although participants were stratified by gender, age, and BMI prior to 
randomization to the two groups, attrition resulted in unequal gender balance in the final 
samples at week 6 (Table 3).  However, when controlling for gender, no significant 
differences were identified between group baseline characteristics indicating they were 
effectively randomized (Table 3).  The initial 3-day food record suggested that the Zone 
group (1718.6 ± 638.0) and control group (1719.9 ± 594.3) were eating a similar quantity 
of calories on average (p = 0.66) despite a relative but insignificant difference (p = 0.23) 
in calculated BMR suggesting an expression of gender variance.  Baseline measurements 
for body composition were similarly distributed as FFM (p = 0.58) and body fat 
percentages (p = 0.54) did not differ significantly between groups.  As a weight loss 
study, change in body composition may be the most important comparative measure to 
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follow. The Zone group had an average of 37.9 ± 10.4% of their weight composed of 
adipose and 62.9 ± 12.1 kg was FFM. The percent body fat in the control group was 40.0 
± 7.9% with 50.8 ± 12.3 kg of FFM.  
Table 3.  Participant Statistics at Baseline1,2 
  Zone (n = 11) Control (n = 11) P-Value³ 
Gender (M/F) 5 / 6 1 / 10 0.06 
Age (years) 40.6 ± 12.7 45.6 ± 12.0 0.58 
Height (cm) 175.3 ± 8.0 167.3 ± 8.2 0.22 
Weight (kg) 100.9 ± 16.1 86.1 ± 23.1 0.46 
BMI (kg/m²) 32.9 ± 5.2 30.8 ± 7.6 0.78 
Waist Circ. (cm) 107.4 ± 12.9 94.9 ± 17.3 0.20 
Body Fat (%) 37.9 ± 10.4 40.0 ± 7.9 0.54 
FFM (kg)4 62.9 ± 12.1 50.8 ± 12.3 0.58 
Activity (kcal· kg-1· wk-1) 53.7 ± 32.2 41.2 ± 25.5 0.63 
Energy Intake – (kcal)5 1718.6 ± 638.0 1719.9 ± 594.3 0.66 
Calculated BMR (kcal) 1815.9 ± 240.4 1532.2 ± 304.4 0.23 
¹Zone – Zone pasta and Zone cereal group; Control – Gluten free pasta and control 
cereal group.  
²Values reported as means ± Standard Deviation 
³ Data normally distributed, analysis by univariate ANOVA controlling for gender.  
4Zone: n = 10; Control: n = 11 
5Zone: n = 7;   Control: n = 8 
 
At the completion of week 6, an independent t-test revealed that participants in 
both groups lost a significant amount of weight over time (p = 0.03) but no significant 
differences were realized between groups (p = 0.96; Table 4).  Participants lost an 
average of 2.9 ± 3.1 kg with the Zone diet and 2.7 ± 2.6 kg with the control diet.  
However, when the data are presented graphically it appears that the Zone diet may have 
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influenced weight loss at trial weeks 3, 4, and 5 (Figure 1).  Following the trend line, the 
Zone diet produced a greater weight loss after the second week (-2.8 kg vs. -1.2 kg) and 
continued to be below the control line until week 5 (-3.6 kg vs. -3.0 kg).  Although not 
significant, a greater disparity between groups appears when plotting the weight loss data 
for female participants only (Figure 2). The females in the Zone group lost more weight 
after week 2 (-3.1 kg vs. -1.8) and the trend continued to be below the control line to the 
end of the trial (-4.3 kg vs. -2.9 kg).  It should be noted that the weekly weight 
measurements were taken in the afternoon (at food pick-up) using the Health o meter 
Doctor’s scale, Neosha, MO, while the baseline and final weight measurements were 
recorded in a fasted state utilizing the Tanita scale, Arlington Heights, IL. 
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Table 4. Week 6 Values and Change from Baseline1,2 
 Zone (n = 11) Control (n = 11) P-value³ 
Weight at Week 6 (kg) 98.1 ± 15.7 83.4 ± 21.0  
Weight Change  -2.9 ± 3.1 -2.7 ± 2.6 0.96 
    
FFM at Week 6 (kg) 64.4 ± 11.8 50.3 ± 11.5  
FFM Change  1.4 ± 3.6 -0.55 ± 1.5 0.02 
    
Body Fat at Week 6 (%) 35.5 ± 9.2 38.8 ± 7.5  
Change in Body Fat -2.9 ± 4.9 -1.2 ± 1.8 0.16 
    
Energy Intake at Week 6 (kcal) 4 1025.0 ± 555.0 941.7 ± 565.6  
Energy Intake Change -328.6 ± 752.0 -229.2 ± 757.0 0.59 
    
Activity Level at Week 3 (kcal· 
kg-1· wk-1) 
45.6 ± 32.6 43.8 ± 51.2 0.88 
Activity Level at Week 6 (kcal· 
kg-1· wk-1) 
43.6 ± 27.3 40.1 ± 21.7 0.63 
¹Zone – Zone pasta and Zone cereal group; Control – Gluten free pasta and control 
cereal group. 
²Values reported as means ± Standard Deviation 
³Data normally distributed, analysis by univariate ANOVA controlling for gender.  
4Zone: n = 5; Control: n = 6 
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Figure 1.  Change in body weight for Zone and Control groups between baseline and 
week-6 of the food trial. Data based on afternoon weekly weights on Health o meter 
Doctor’s scale, Neosha, MO. 
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Firgure 2.  Change in female body weight for Zone and Control groups between baseline 
and week-6 of the food trial. Data based on afternoon weekly weights on Health o meter 
Doctor’s scale, Neosha, MO. 
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Analyzing change in body composition from baseline, the change in FFM was 
significant (p = 0.02) between the two groups at week-6 (Table 4).  A univariate analysis 
was conducted to control for gender.  The Zone group had a mean increase in FFM of 1.4 
± 3.6 kg while the control group saw a mean decrease in FFM equal to -0.6 ± 1.5 kg. 
Physical activity and exercise did not appear to effect change in FFM over the course of 
the study as the activity level between groups remained similar (week 3; p = 0.88; week 
6; p = 0.63).  The significance reported in FFM was not related to the change in body fat 
percentages as neither group saw a statistical advantage with this measure of body 
composition (p = 0.16).  Both groups registered a reduction in body fat:  -2.9 ± 4.9% and 
-1.2 ± 1.8% for the Zone and control group respectively (ns; p = 0.32).    
Energy intake was less at week 6 in both groups compared to baseline levels and 
was calculated through data analysis of a series of 3-day records. Participants on the Zone 
diet reported a mean difference of -329 ± 752 kcal while the control diet reported 
consuming 229 ± 757 less calories daily (p = 0.59 for interaction;  p = 0.12 for time 
effect).  Essentially, both groups maintained a similar caloric intake over the duration of 
the study regardless of the macronutrient composition of the meals they ate (Table 3).  
However, only about half the participants completed the 3-day records (Zone: n = 5, 
Control: n = 6) which limits the statistical interpretation of these data.  In addition to the 
3-day record, participants kept daily records on how well they adhered to the diet 
interventions (Table 5). Participants were instructed to track the intake of the 3 meals 
they received every day and adherence was calculated by the total meals they ate for the 
duration of the study. The control group reported an average of 81.1 ± 6.9% adherence to 
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the prepared meals and the zone group reported 83.4 ± 12.5%, but the differences 
between groups were insignificant (p = 0.53). 
Table 5. Adherence Based on Percent Food Items Consumed (Target = 3x/day)1,2 
 Zone (n = 8) Control (n = 10) P-value³ 
Adherence (%) 83.4 ± 12.5 81.1 ± 6.9 0.53 
¹Zone – Zone pasta and Zone cereal group; Control – Gluten free pasta and control 
cereal group. 
²Values reported as means ± Standard Deviation 
³Data normally distributed, analysis by independent t-test controlling for gender. 
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Chapter 5 
DISCUSSION 
 This randomized, parallel-arm, food trial demonstrated that consuming an energy-
restricted diet higher in protein content improved FFM outcomes more than a high 
carbohydrate, isocaloric diet, but both diets resulted in significant body weight reductions 
over time.  Both diet groups lost similar weight after 6 weeks (~ 3% body mass), however 
the Zone group gained FFM during this time while the percent contribution of FFM was 
about 20% of the weight loss experienced in the control group.  The change in FFM 
between the two groups was not related to their body fat percentages as both group 
experienced similar results. Despite a difference of about 2 kg in FFM between them, 
both groups retained a statistically equal amount of fat mass.  
The FFM sparing effect of the Zone group was anticipated as other research has 
reported comparable findings with a similar high protein profile (30% of energy intake).  
Over a 12 week energy-restricted weight loss intervention, Leidy et al. observed that their 
high protein group lost a similar amount of weight (~9 kg) compared with the normal 
protein group (18% protein) but had only about a 1.5 kg loss of FFM compared to 2.8 kg 
loss respectively (78).  Our study compared groups with a larger difference in protein 
intake (29% vs. 9% energy) which may explain why the Zone group had a much larger 
change in FFM between the two groups. Similarly, a meta-analysis focused on high 
protein hypocaloric diets reported that increased protein intake was associated with the 
sparing of FFM similar to levels provided in the Zone group (66). They found no 
significance between diet type and weight loss or body fat percentages which is 
consistent with our results.  
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Kreiger et al. concluded in their meta-analysis that the change in body 
composition related to high protein intake was independent of energy intake which is also 
consistent with our findings (66). Both the Zone and control groups reduced their caloric 
intake by similar amounts and were essentially consuming the same amount of energy 
through the duration of the trial. In addition, both group’s activity levels remained 
statistically similar suggesting the change in FFM was independent of both energy intake 
and energy expenditures. As a result the increase in protein intake seems to be 
responsible for mitigating FFM loss under energy-restricted conditions.  FFM is strongly 
associated with BMR as it accounts for roughly 60-70% of total daily energy expenditure 
(79).  The implication is that a diet high in protein could have significant benefit for 
sustained weight loss as more FFM is spared over time.  Conversely, losing FFM over 
time can make weight loss more difficult and prevent the realization of the beneficial 
effects of reducing body fat on comorbidities. The lack of long-term studies focused on 
the benefits of FFM preservation make it difficult to define any clinical significance as it 
relates to weight loss (60). 
No statistically significant differences were observed between the two diets for 
change related to body fat percentage (p = 0.16) despite the superior change in FFM 
experienced by the Zone group compared to the control.  Results from other studies have 
contradicted these finding as they reported body fat percentage decreased significantly 
with high-protein diets compared to their high-carbohydrate counterparts (80, 81). 
Layman et al. found that a high-protein diet had a significantly (p < 0.05) greater ratio of 
fat loss to lean mass compared with the high-carbohydrate group over a 10 week period 
(80).  Our treatment period of only 6 weeks may have been too short for changes in body 
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fat to reach significant levels. However, Clifton et al. may offer another explanation for 
why changes in body fat were significant in some studies but not in ours (53). They found 
that body fat percentages were significantly different between high-protein and high-
carbohydrate diets only when the participants had high TAG levels at baseline (>1.54 
mmol/L). Participants with lower levels did not see any change between the two 
treatment groups. The significant change in FFM independent of loss in body fat percent 
may be more of a reflection of the participant TAG levels than the timeframe of the 
treatment period.   
As a weight loss trial, the design of our weight loss plan was successful as both 
treatment groups lost a significant amount of weight over time (p = 0.03).  These results 
are not uncommon when compared to related research studies.  However, studies on 
short-term high-protein diets like ours were more likely to see significant differences 
between groups where long-term studies were more likely to see similar results.  Triffoni-
Melo et al. noted a significant difference between treatment groups after only 8 days (54).  
Other researchers found significant reductions in body weight over a 6 week diet 
intervention (51).  Skov et al. found that increased protein intake resulted in greater 
weight loss at 3 months and to a lesser extent at 6 months (57).  The statistical weight 
loss advantage continued to support high protein diets up to a period of 3 months but 
weaned at the 12 month mark (48).  High-protein weight loss studies focusing on 6 
months or greater tend to demonstrate similar results to ours. In fact when diet periods 
were extended to 52 weeks, a number of studies reported significant weight loss over 
time but not between treatment groups (59, 60, 76). Despite our findings, it appears high-
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protein diets are more efficacious for weight loss under short-term dieting conditions and 
are at least as effective for weight loss as other diet approaches in the long-term.  
Although not statistically significant, the graphical representation of weight loss 
between our treatment groups appears to highlight the Zone diet as being more effective 
than the high-carbohydrate control. The trend at weeks 2, 3, and 5 shows that the zone 
group had lost more weight than the control group and appeared to be more effective as a 
result. However, by week 6 the Zone group appeared to have gained enough weight back 
to comparable measures as the control.  The gender differences between test groups led 
us to analyze the trend line between females to determine what effect sex may have 
impacted on the chart effect. Once this was completed, the trend seemed to improve to a 
greater extent for the Zone group suggesting a possible relation between the Zone diet 
and weight loss. A possible explanation for the weight gain by week 6 could be 
participant fatigue for the engineered carbohydrate product offered in the Zone treatment 
group. The pasta product has a different texture and mouthfeel to the control pasta which 
may have resulted in reduced participant adherence. By the final week it is possible 
participants may have begun to eat foods not in compliance with the recommendations 
made to them prior to the study.  While both groups had similar adherence scores at the 
end of the trial, these scores were not analyzed for week-by-week effect.  
The increased satiety related to protein intake, as reported by previous research, 
was believed to increase adherence to the Zone diet group on account of its increased 
protein content (27).  Pesta et al noted diets higher in protein intake resulted in increased 
feeling of satiety which resulted in a decrease in energy intake.  In addition, Weigle et al 
noted feelings of fullness increased while hunger decreased in participants eating a high 
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protein diet (43).  The increased protein content of the Zone diet was thought to improve 
adherence to an isocaloric diet as participants would have more feelings of fullness and 
less feelings of hunger (desire to eat) despite eating less food. Adherence was measured 
in this study by how often participants ate the test meals and not how well they managed 
their diet as a whole. With both groups instructed to eat their test meals, using them as an 
indicator of adherence may have failed to address whether or not the satiety effects of 
protein improved participant adherence. The similarity in adherence between the two 
diets might suggest that participants were following instructions and not influenced by 
the diet type as a result. The fact both participant groups maintained similar levels of 
energy intake through the duration of the trial suggests the protein content between the 
diets had little effect on overall food intake.  
Limitations.  This food trial had a number of limitations to consider.  As with 
most food trials our study was impacted by high attrition rates.  Only 54% of the initial 
enrollment finished the duration of the trial as 19 participants dropped out for a variety of 
reasons. The attrition rates were 6% higher than we had anticipated which may limit the 
generalizability of our findings as a result. However, the dropout rate was comparable to 
other similar weight loss trials (50, 60, 82).  Participant adherence to the treatment and 
diet recommendations are subjective and not entirely accurate. We attempted to maintain 
simple guidelines to follow and tracked their diets in order to mitigate participant bias but 
we have no means to measure the effectiveness of our efforts. Similarly, diet records are 
often not reliable and highly volatile as a measure of energy intake. We attempted to 
improve the accuracy of diet records by evaluating the most complete diet record each 
week and then projecting that evaluation as a representation for the entire week.  The 
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length of the trial presented adherence and compliance challenges for the participants 
resulting in issues with reliability after the crossover. Without an appropriate wash-out 
period, the first phase of the trial may have presented carry-over effects which could not 
be sufficiently ruled out as an explanation for the differences noted between the 
treatments after the crossover. As a result, only the first 6 weeks were used for data 
analysis. 
Our initial and final weight measures were recorded in a fasted state on a Tanita 
scale while the weekly weights were measured in the afternoon on a Health o meter 
Doctor’s scale.  The variation between how body weight was tracked may have impacted 
the significance of our results. In addition, the Tanita scale was used to determine FFM 
and percent body fat which is not as valid of a measure as a DEXA Scan would have 
provided. Similarly, the way in which BMR was measured may have impacted the 
significance of our results as well.  The Mifflin-St. Jeor calculation provided a rough 
estimate of BMR, but the use of a respiration chamber or an indirect calorimeter would 
have provided a much more accurate measure. 
This study may very well be the first of its kind to truly blind participants from 
diet type by masking the sources of protein.  Both the Zone and the control groups 
received cereal and pasta dishes and had no way to determine one type was higher protein 
than the other. In other similar food trials, participants know they are eating more protein 
as they are instructed to eat more protein rich food sources like meat and dairy. In other 
Zone trials, participants are instructed to eat a diet high in meat and vegetables while 
typically high carbohydrate food sources like pasta and cereal are omitted.  Moreover, in 
many published trials, participants were given the diet book to follow (e.g., the Atkins 
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book or the Zone book); hence, participants clearly knew which diet they were following.  
In addition, while participants did receive structured food packages, the bulk of their diet 
was ad libitum increasing generalizability to the population as a whole. Prior to 
enrollment, participants were screened for an extensive list of exclusion criteria to 
mitigate intervening variables from expressing influence into our data. The inclusion 
criteria into the study ensured participants were statistically similar between both groups 
which promote validation for our results.  
Conclusions.  The parallel-arm food trial suggests that energy-restricted diets are 
effective for short-term weight loss.  Additionally, the results implicate high-protein diets 
as possibly having a protective effect on body composition as FFM was spared during the 
trial. Conversely, FFM was lost with a high-carbohydrate diet.  The macronutrient profile 
of the diet does not appear to influence calorie intake, but it does appear to influence the 
quality of weight loss.  Other measures of body composition and overall health outcomes 
need to be investigate further by future studies to appropriately identify the potential 
health effects between these diet types. More research is needed to determine effective 
techniques to increase participant adherence to the diets and to reduce attrition rates 
common with food trials.  
In summary, hypothesis 1 was rejected as both participant groups lost a 
significant amount of weight over time but no significance was found between the two 
groups.  Hypothesis 2 was supported as the experiment group resulted in a net gain in 
FFM which was significantly different than the control group which resulted in a net loss 
in FFM. Hypothesis 3 was rejected as both participant groups had similar energy intake 
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and reported compliance to their respective diets indicating the satiating effect of protein 
had no impact on adherence during this weight loss trial.   
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CONSENT FORM 
Effects of Re-Engineered Carbohydrate Meal Plans  
on Body Weight and Other Health Parameters 
 
INTRODUCTION 
The purposes of this form are to provide you (as a prospective research study participant) 
information that may affect your decision as to whether or not to participate in this 
research and to record the consent of those who agree to be involved in the study. 
 
RESEARCHERS 
Dr. Carol Johnston, Professor in the School of Nutrition and Health Promotion, and 
Jessica Knurick, a doctoral student, have invited your participation in a research study 
that will last 12 weeks.   
 
STUDY PURPOSE 
The purpose of this research is to evaluate the effect of re-engineered carbohydrate 
(REC) meal plans on body weight and biomarkers of health including blood cholesterol, 
blood glucose, and satiety.  Dr. Barry Sears, creator of the Zone Diet, has developed a 
new line of Zone 1-2-3 foods using his patented ‘Molecular Baking’ to balance the 
protein:carbohydrate ratio of commonly ‘high carbohydrate’ foods.  The REC used in this 
trial is a pasta product.  Dr. Sear’s Inflammation Foundation is funding this trial. 
 
DESCRIPTION OF RESEARCH STUDY 
You have informed us that you are healthy, 20-75 y of age, and not a smoker and that you 
do not have any food allergies or diet restrictions.  If you decide to participate in this 
study, you will join a study examining the effect of a new pasta product (designed to have 
more protein and less carbohydrate) on body weight and biomarkers of health including 
blood cholesterol and glucose. To be eligible for the diet program, your TG/HDL ratio 
will need to be >3.5 for men and >2.5 for women.  We will test this for you.  You will be 
asked to consume the foods provided to you during the 12 week study, but you may add 
vegetables and other foods to the meals as desired.  Meal plans will be individualized to 
meet your specific calorie needs; you will receive the new pasta for 6 weeks and the 
traditional pasta for 6 weeks (however, the order of pasta is randomized and neither you 
or the study coordinator will know which pasta you are consuming during the study. You 
will be asked to record diet adherence daily and not to change your typical physical 
activity pattern or consume dietary supplements during the study.  A health history 
questionnaire will be completed at the initial visit and a short mood survey will be 
completed on 6 occasions during the study.  The study involves 13-16 visits (at weekly 
intervals) to the test site at the ASU Nutrition Labs on the Phoenix Downtown Campus. 
These visits will take ~1/2 hour and include picking up weekly food allotments.  You will 
be provided with a cooler tote on wheels to easily take the food to your car.  Fasting 
blood samples will be collected at 4 of these visits.  A trained phlebotomist or registered 
nurse will draw all blood samples; each sample of blood is about 2 tablespoons.   
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At week 6 and week 12, body composition (relative amounts of fat and lean tissue) will 
be determined by using an FDA‐approved bone density measurement machine. The 
procedure is called Dual‐energy X‐ray Absorptiometry (DEXA). You will be asked to 
lie face up on an open, padded table for 7 minutes while the scanner arm of the DEXA 
machine passes over the entire body. You can wear regular clothing but any metal must 
be removed.  You will be exposed to a small amount of radiation (1‐4 microSieverts) 
that is within an acceptable range per the FDA. For comparison, you would be exposed to 
approximately 80 microSieverts on a transatlantic airline flight of 8 hours, 50 
microSieverts living in Denver, Colorado, at an elevation of 5,000 feet for approximately 
4 weeks, or 30 to 40 microSieverts during a typical chest x‐ray. (For test accuracy, you 
will be asked about test procedures using barium/isotopes in the recent past and be 
scheduled for visit 1 with an adequate lapse of time.) 
 
If you say YES, then your participation will last for 12 weeks at the Arizona State 
University Downtown Phoenix Campus.  Approximately 45 subjects will be recruited for 
this study. 
 
RISKS 
Potential risks of participating in this study involve general risks associated with giving a 
blood sample such as bruising or irritation at the site of venipuncture and faintness.  Meal 
plans are composed of commercial breakfast items (cereals/bars/shakes) and the lunch 
and dinner meals will be prepared in the ASU Nutrition Program’s metabolic kitchens 
and frozen in appropriate portion sizes.  Trained staff will prepare the meals under the 
direction of a Chef, and these staff will hold food handlers certificates from Maricopa 
County.  Meals will be provided in coolers so the food will be preserved during the drive 
home.   
 
Anytime you are exposed to radiation there is potential risk. If there is ANY chance of 
being pregnant then you should not undergo the DEXA scanning. Females will take a 
urine pregnancy test prior to the DEXA scan. A certified X‐ray technician will complete 
all DEXA scans. As with any research, there is some possibility that you may be subject 
to risks that have not yet been identified. 
 
BENEFITS  
There is a possibility that you will lose some weight during this trial.  In addition, your 
participation in the research may contribute to knowledge regarding the efficacy of a new 
food product for weight loss and improved health biomarkers.   
 
NEW INFORMATION 
If the researchers find new information during the study that would reasonably change 
your decision about participating, then they will provide this information to you. 
 
CONFIDENTIALITY 
All information obtained in this study is strictly confidential unless disclosure is required 
by law. The results of this research study may be used in reports, presentations, and 
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publications, but the researchers will not identify you.  In order to maintain 
confidentiality of your records, Dr. Carol Johnston will assign you a participant number.  
Your name will not appear on any records aside from this consent form.  This form will 
be kept in Dr. Carol Johnston’s locked office to maintain your confidentiality.  
 
 
WITHDRAWAL PRIVILEGE 
It is OK for you to say no. Even if you say yes now, you are free to say no later, and 
withdraw from the study at any time.  Your decision will not affect your relationship with 
Arizona State University or otherwise cause a loss of benefits to which you might 
otherwise be entitled. 
 
COSTS AND PAYMENTS 
The researchers want your decision about participating in the study to be absolutely 
voluntary. Yet they recognize that your participation may pose some costs related to time 
and travel. Participants will receive cash incentives during the trial:  $15, $25, $35, $45, 
and $55 at study weeks 0 (start of trial), 3, 6, 9, and 12.  [total = $175]  
 
COMPENSATION FOR ILLNESS AND INJURY 
If you agree to participate in the study, then your consent does not waive any of your 
legal rights. However, no funds have been set aside to compensate you in the event of 
injury.  
 
VOLUNTARY CONSENT 
Any questions you have concerning the research study or your participation in the study, 
before or after your consent, will be answered by Carol Johnston, 
carol.johnston@asu.edu [or (602)827-2265] and Jessica Knurick, jknurick@asu.edu. 
  
If you have questions about your rights as a subject/participant in this research, or if you 
feel you have been placed at risk; you can contact the Chair of the Human Subjects 
Institutional Review Board, through the ASU Office of Research Integrity and 
Assurance, at 480-965 6788.  This form explains the nature, demands, benefits and any 
risk of the project.  By signing this form you agree knowingly to assume any risks 
involved.  Remember, your participation is voluntary.  You may choose not to participate 
or to withdraw your consent and discontinue participation at any time without penalty or 
loss of benefit.  In signing this consent form, you are not waiving any legal claims, rights, 
or remedies.  A copy of this consent form will be offered to you.   
 
 
Your signature below indicates that you consent to participate in the above study.   
 
 
 
___________________________ ____________________________________ 
Subject's Signature              Printed Name                Date 
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__________________________________     ___________________________ 
email                                                                 phone contact number 
 
 
 
INVESTIGATOR’S STATEMENT 
"I certify that I have explained to the above individual the nature and purpose, the 
potential benefits and possible risks associated with participation in this research study, 
have answered any questions that have been raised, and have witnessed the above 
signature. These elements of Informed Consent conform to the Assurance given by 
Arizona State University to the Office for Human Research Protections to protect the 
rights of human subjects. I have provided (offered) the subject/participant a copy of this 
signed consent document." 
 
 
 
Signature of Investigator_________________________________   Date_____________ 
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APPENDIX C 
HEALTH HISTORY QUESTIONAIRRE 
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APPENDIX D 
FOOD LIST 
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APPENDIX E 
PHYSICAL ACTIVITY QUESTIONAIRRE 
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ID# ___________________                    Study week/Date of visit __________________ 
 
 
 
Please circle the number of times you did the following kinds of 
exercises for more than 15 minutes last week. 
 
  
• Mild exercise (minimal effort): 
Easy walking, golf, gardening, bowling, yoga, fishing, horseshoes, archery, 
etc. 
 
Times per week:     0   1   2   3   4   5   6   7   8   9   10   11  12   13   14+ 
  
• Moderate exercise (not exhausting): 
Fast walking, easy bicycling, tennis, easy swimming, badminton, dancing, 
volleyball,  
baseball, etc. 
 
Times per week:     0   1   2   3   4   5   6   7   8   9   10   11  12   13   14+ 
  
• Strenuous exercise  activities (heart beats rapidly): 
Running, jogging, hocky, football, soccer, squash, basketball, cross country 
skiing,  
judo, roller skating, vigorous swimming, vigorous long distance bicycling, etc. 
 
Times per week:     0   1   2   3   4   5   6   7   8   9   10   11  12   13   14+ 
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APPENDIX F 
PREPARED MEAL RECIPES 
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Orzo Recipes 
"Rice" and Tomatoes Broccoli Orzo 
Yield: 1  serving  
Total time: 15 minutes 
Yield: 1  serving  
Total time: 15 minutes 
Ingredients: 
1/2 cup  Zone orzo 
1 tsp  dehydrated onion flakes 
1/4 tsp  chili powder 
1/4 tsp  oregano 
1/4 tsp  cumin 
1/4 tsp  garlic powder 
1/4 tsp  cayenne pepper - (optional) 
1/4 cup canned tomatoes -  diced  with 
 sauce or fresh or  tomato sauce 
1/2 tsp  lime juice - fresh squeezed 
  salt - to taste 
1 1/2 tsp  extra virgin olive oil 
Ingredients: 
1/2 cup  Zone orzo 
1 cup  frozen broccoli 
1 tbsp  sundried tomatoes 
1/4 tsp  garlic powder 
1/4 tsp  turmeric 
  salt & pepper 
1 tbsp  fresh squeezed lemon juice 
1 1/2 tsps extra virgin olive oil 
 
Instructions: 
Prepare Zone orzo according to package 
directions. Drain and put back in sauce pan. Stir in 
remaining ingredients and enjoy. 
 
Instructions: 
Cook Zone orzo as directed with broccoli. Drain. 
Reserve 1/2 cup of liquid and set aside. Add orzo 
back to pan. Stir in remaining ingredients and heat 
to desired temperature. Add some reserved pasta 
water it you want a little "sauce". 
 
Three Bean Salad White Bean Orzo 
Yield: 1  serving  
Total time: 15 minutes 
Yield: 1  serving  
Total time: 20 minutes 
Ingredients: 
1/2 cup Zone orzo 
1/2 cup green beans - raw chopped (or 
 cooked and cooled with orzo) 
1 tbsp kidney beans canned - 
 rinsed/drained 
1 tbsp garbanzo beans canned     - 
 rinsed/drained 
1 tbsp parsley - chopped 
1 1/2 tsps extra virgin olive oil 
1 tbsp lemon juice - to taste 
 salt and pepper - to taste 
Ingredients: 
1/2 cup  Zone orzo 
1 1/2 tsps olive oil 
1 clove  garlic 
1  plum tomato - chopped 
2 tbsps  cannellini beans, Bush's -  
  rinsed/drained 
  basil - to taste 
  oregano - to taste 
1 tbsp  parsley - chopped 
1 1/2 tsps grated Parmesan 
  salt and pepper - to taste 
Instructions: 
Cook Zone orzo (add green beans near the end) as 
directed and let cool. Meanwhile, combine 
remaining ingredients in a good sized bowl and 
season to taste. Stir in orzo. 
 
Instructions: 
Cook Zone orzo as directed. Reserve 1/2 cup of 
liquid and drain. Meanwhile, heat olive oil and 
garlic in a medium saucepan and season. Add 
chopped tomato, beans and dried herbs. Add some 
of the reserved pasta liquid and stir to desired 
sauce consistency. Pour over pasta and season with 
Parmesan, salt and pepper.  
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Orange and Dill Orzo Awesome Pasta Salad 
Yield: 1  serving  
Total time: 15 minutes 
Yield: 1  serving  
Total time: 20 minutes 
Ingredients: 
1/2 cup  Zone orzo 
3/4 cup  vegetable broth 
2 tbsps  fresh-squeezed orange juice - 
(use a good juice orange) and some zest 
1 tbsp  finely minced fresh dill - (or 1 
teaspoon dried dill) 
2 tsps  pistachio nuts - minced 
1 tsp  extra virgin olive oil 
1/2 cups broccoli slaw Dole - raw 
Ingredients: 
1/2 cup Zone orzo 
7 cherry tomatoes - halved 
1/2 oz low-fat provolone cheese - cubed 
1/2 green bell pepper - chopped 
1 tbsp black olives - drained, sliced 
1 tbsp pimentos - drained, chopped 
1 tsp extra virgin olive oil 
1 tbsps fresh-squeezed lemon juice - to taste 
 garlic powder - to taste 
 Italian seasoning - to taste 
 salt and pepper - to taste 
 water. 
Instructions: 
Heat oil in a small saucepan over medium heat; 
add onion. Cook, stirring frequently, until tender. 
Add a tablespoon of the broth as needed. 
Meanwhile bring broth to a boil. Add Zone orzo 
and stir until broth is almost all absorbed, about 5 
minutes. Set aside. Grate the zest from the orange 
and then squeeze out all the juice. Fluff the Zone 
orzo thoroughly with a fork and add both the zest 
and juice, along with the dill. Mix well. Cover 
tightly (remove comma) and set aside until serving 
time. Without removing the cover, heat just before 
serving in a microwave or a regular oven at 325°F. 
Serve hot over the broccoli slaw, sprinkled lightly 
with pistachios and drizzled with extra virgin olive 
oil. 
Instructions: 
Prepare Zone orzo according to package 
directions. Drain and rinse in cold water to stop 
cooking; drain again. Set aside to cool. Meanwhile 
whisk the extra virgin olive oil, lemon juice, garlic 
powder, Italian seasoning, salt and pepper together 
in a small bowl. (If you like a lot of dressing add 1 
tablespoon water and more lemon juice.) In a large 
bowl combine pasta with tomatoes, cheese, green 
pepper, olives, and pimentos. Pour in salad 
dressing and toss to coat. 
 
 
Strawberry Almond Breakfast Pudding Spicy Kale Orzo 
Yield: 1  serving  
Total time: 10 minutes 
Yield: 1  serving  
Total time: 10 minutes 
Ingredients: 
1/2 cup Zone orzo 
2 tsps almond butter 
2 tbsps 0%-Fat Greek yogurt 
sprinkle pumpkin pie spice 
1/2 cup strawberries - quartered 
 
Ingredients: 
1/2 cup  Zone orzo 
3/4 cup  beef broth 
1 cup  kale - chopped 
1 clove  garlic - crushed 
1/4 tsp  turmeric    
1 1/2 tsps extra virgin olive oil 
Instructions: 
Prepare orzo according to package directions. 
Drain. Stir in the almond butter and yogurt. Top 
with pumpkin pie spice and strawberries. 
 
Instructions: 
Bring broth to a boil. Add Zone orzo and kale. Stir 
until broth is almost all absorbed, about 4 minutes. 
Cover and let rest for 4 minutes. Stir in garlic, 
turmeric and extra virgin olive oil. 
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Cold Sesame Slaw Vegetable Orzo 
Yield: 1  serving  
Total time: 10 minutes 
Yield: 1  serving  
Total time: 15 minutes 
Ingredients: 
1/2 cup  Zone orzo 
1/2 cup  broccoli slaw Dole  
1/4 cup  red bell pepper - sliced 
1 tbsp  water chestnuts - canned, 
chopped  
1/4  tangerine - cut in half across the 
  segments. Separate that in 1/2 
  Squeeze the remainder  for juice 
1 tbsp  fresh-squeezed tangerine juice - 
  (squeeze the remainder) 
1 tsp  sesame seeds 
2 tbsps  rice wine vinegar 
1 tsp  sesame oil 
Ingredients: 
1/2 cup  Zone orzo 
3/4 cup  chicken broth 
1 tsp  olive oil 
1 clove  garlic - pressed 
3 hearts artichoke hearts canned - quartered 
3 tbsp  roasted red pepper 
1/4 cup  tomatoes - diced 
1 tbsp  black olives - sliced 
2 tsps  dried parsley 
 
Instructions: 
Prepare Zone orzo according to package 
directions. Drain and rinse in cold water to stop 
cooking. Drain and rinse again. Set aside to cool. 
Meanwhile, mix broccoli slaw with pepper slices, 
water chestnuts, tangerine pieces (only 1/4 the 
tangerine), tangerine juice, sesame seeds, rice wine 
vinegar, and sesame oil. 
 
Instructions: 
Bring the Zone orzo and chicken broth to a boil, 
stirring occasionally. Lower heat to medium and 
cook until broth is absorbed, stirring all the while, 
about 6 minutes. Heat olive oil in skillet. Add 
garlic, artichoke hearts, roasted red peppers, 
tomatoes, black olives, parsley and orzo. Heat until 
warmed through. Transfer to a serving bowl and 
enjoy! 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
82
Fusilli Recipes 
Fusilli with Spinach Fusilli with Spinach and Tomato 
Yield: 1  serving  
Total time: 20 minutes 
Yield: 1  serving  
Total time: 20 minutes 
Ingredients: 
1 cup  Zone fusilli 
1 1/2 tsps olive oil 
1/4 cup  onion - chopped 
1/2 clove garlic - pressed 
5 oz  baby spinach 
1 tbsp  fresh squeezed lemon juice 
1 tsp  fresh dill or 1/3 dried 
  salt and pepper - to taste 
Ingredients: 
1 cup  Zone fusilli 
2/3 cup  tomato sauce 
1 1/2 tsps olive oil 
2 1/2 cups baby spinach 
1 tsp  grated Parmesan 
  oregano - to taste 
  salt and pepper - to taste 
 
Instructions: 
Cook Zone fusilli as directed. Reserve 1/2 cup of 
liquid and drain. Meanwhile, heat olive oil and add 
onion. Sauté for a few minutes. Add garlic and 
sauté until wilted. Add baby spinach to wilt for 
about 30 seconds. Toss into fusilli and moisten 
with reserved liquid (comma out) to desired 
consistency, adding slowly (you may not want to 
use all). Sprinkle with herbs, salt and pepper. 
Instructions: 
Cook Zone fusilli as directed. Reserve 1/2 cup of 
liquid and drain. Meanwhile, heat olive oil and add 
onion. Sauté for a few minutes. Add garlic and 
sauté until wilted. Add baby spinach to wilt for 
about 30 seconds Toss into fusilli and moisten 
with reserved liquid, to desired consistency, 
adding slowly (you may not want to use all). 
Sprinkle with cheese, oregano, salt and pepper. 
 
Fusilli with Broccoli Fusilli with Red Clam Sauce 
Yield: 1  serving  
Total time: 20 minutes 
Yield: 1  serving  
Total time: 15 minutes 
Ingredients: 
3/4 cup  Zone fusilli 
1 1/2 tsps olive oil 
1/2 cup  onion - chopped 
1/2 clove garlic - pressed 
1/2 cup  chicken broth 
1 cup  broccoli – florets (whole or 
  chopped) 
  herbs - to taste (such as thyme, 
  sage, oregano or tarragon) 
  salt and pepper - to taste 
Ingredients: 
3/4 cup  Zone fusilli 
1  tsp  olive oil 
1/2 cup  tomato sauce 
1/4 cup  Chicken of the Sea minced 
clams 
2 tbsps  lemon juice 
2 tbsps  fresh parsley - chopped 
1/4 tsp  thyme - ground 
1 tbsp  grated Parmesan 
  salt and pepper - to taste 
Instructions: 
Cook Zone fusilli as directed. Reserve 1/2 cup of 
liquid and drain. Meanwhile, heat olive oil and add 
onion. Sauté for a few minutes, add garlic and 
sauté until wilted. Add broccoli and cover for 5 
minutes. Toss into fusilli and moisten with 
reserved liquid, to desired consistency, adding 
slowly (you may not want to use all). Sprinkle 
with herbs, salt and pepper. 
Instructions: 
Cook Zone fusilli as directed. Drain and toss with 
olive oil. Meanwhile, heat sauce in a medium 
saucepan. Add clams, lemon juice, parsley and 
thyme. Simmer for 5 minutes. Serve over hot 
fusilli seasoned with grated Parmesan, salt and 
pepper. 
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Apple-Walnut Pasta with Chicken Sausage Fusiili Fagiole 
Yield: 1  serving  
Total time: 15 minutes 
Yield: 1  serving  
Total time: 20 minutes 
2/3 cup  Zone fusilli 
1/2 tsp  olive oil 
2 tbsp  dry white cooking wine 
1 slice  onion 
1/2 link  Al fresco sweet apple chicken 
  sausage - sliced 
1/4 medium apple - diced 
3/4 tsp  walnuts - crushed, toasted if you 
  want 
1 cup  baby spinach leaves 
 
Ingredients: 
1 cup  Zone fusilli 
1 1/2 tsps olive oil 
1 clove  garlic 
2  plum tomatos - chopped 
  basil - to taste 
  oregano - to taste 
1 tbsp  parsley - chopped 
2 tbsps  cannellini beans, Bush's -  
  rinsed/drained 
1 1/2 tsps grated Parmesan 
  salt and pepper - to taste 
Instructions: 
Cook Zone pasta as directed. Drain. Reserve 1/2 
cup of liquid and set aside. Meanwhile, heat oil 
and wine in nonstick skillet. Sauté onion until 
translucent, about 3-4 minutes. Add cut sausage 
and cook until heated through, about 2 minutes. 
Stir in diced apples, walnuts, spinach and reserved 
pasta. Add some of the reserved water if needed. 
Cook for an additional 2 minutes until all 
ingredients are warm and spinach is wilted.  
Instructions: 
Cook Zone fusilli as directed. Reserve 1/2 cup of 
liquid and drain. Meanwhile, heat olive oil and 
garlic in a medium saucepan and season. Add 
chopped tomato, beans and dried herbs. Add some 
of the reserved pasta liquid and stir to desired 
sauce consistency. Pour over pasta and season with 
Parmesan, salt and pepper.  
 
 
Mediterranean Salad Spinach Basil Pesto Pasta w/ Tomato Salad 
Yield: 1  serving  
Total time: 15 minutes 
Yield: 1  serving  
Total time: 20 minutes 
Ingredients: 
1 cup  Zone fusilli 
4  cherry tomatoes - halved 
1/2 cup  cucumber - chopped 
2  olives - chopped 
1/2 oz  feta cheese - crumpled 
1/2 tsp  extra virgin olive oil 
2 tbsps  fresh-squeezed lemon juice - 
juice   of 1 lemon 
  oregano - to taste 
  black pepper 
 
Ingredients: 
3/4 cup  Zone fusilli 
2 cups  baby spinach 
1/4 cup  roasted red pepper 
1/4 cup  basil leaves - packed 
1 clove  garlic - peeled and cut in half 
1 1/2 tbsps water - more if needed 
1/2 tbsp  extra virgin olive oil 
Side Salad: 
2  tomatoes - cut into 6 slices 
1/2 oz  Polly-o fat free mozzarella 
6 leaves  basil 
Instructions: 
Cook Zone pasta as directed and let cool. 
Meanwhile, cut the tomato and cucumber into 
chunks. Add to cooled pasta along with remaining 
ingredients. 
Instructions: 
Cook Zone fusilli as directed. Drain and set aside. 
Meanwhile, place the spinach, basil, garlic, water 
and olive oil into a food processor or blender. 
Blend until smooth and toss with pasta. Serve 
immediately with cheese and basil on top of 
tomato slices. 
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American Chop Suey with Salad Baked Fusilli with Zucchini 
Yield: 1  serving  
Total time: 20 minutes 
Yield: 1  serving  
Total time: 30 minutes 
Ingredients: 
2/3 cup  Zone fusilli 
1 tsp  olive oil 
1/2  celery stalk - chopped 
3 tbsps  onion - diced 
1 clove  garlic - minced 
3 tbsps  red bell pepper - diced 
1 1/2 oz  extra-lean ground turkey breast 
  cooking spray 
1/2 (14.5 oz) can canned tomatoes - diced 
1/4 tsp  crushed red pepper flakes 
1/4 tsp  fresh chopped basil 
  salt and pepper - to taste 
1 tbsp  fresh-squeezed lemon juice 
1 tsp  extra virgin olive oil 
1/2 cup  lettuce 
1/4  tomato 
1/4  cucumber 
Ingredients: 
3/4 tsp  olive oil 
1/2 med  zucchini - cut into small cubes 
1/2 cup  green beans - trimmed and cut 
  diagonally in half 
1/2 (14 oz) can canned tomatoes - diced 
3/4 cup  Zone fusilli 
1/2 cup  tomato sauce 
2 tbsps  water 
1/4 tsp  Italian seasoning 
1 slice  Canadian bacon - chopped to 
bite-  sized pieces 
  salt and pepper - to taste 
1 1/2 tbsps mozzarella cheese, shredded, 
part   skim milk 
1 tsp  grated Parmesan 
  cooking spray 
1/2 tsp  extra virgin olive oil 
Instructions: 
Cook Zone fusilli 3-4 minutes. Drain and set aside. 
Meanwhile, heat oil to medium/high in a skillet. 
Add celery and onion. Cook for a few minutes first 
and then add the garlic and peppers. Remove from 
pan, spray with cooking spray and sauté turkey 
until no longer pink. Return veggie mixture to pan 
along with par-cooked fusilli. Top with canned 
tomatoes and crushed red pepper, stir well, and 
cover and simmer for about 8 minutes. Top with 
fresh basil just before serving. Make a small side 
salad.    
Instructions: 
Preheat oven to 375°F. Heat oil in skillet over 
medium-high heat. Add zucchini and green beans. 
Cover and cook, stirring occasionally for 5 
minutes. Stir in tomatoes (with juice), tomato 
sauce, water, Italian seasoning, Canadian bacon, 
salt and pepper. Cover and simmer 4 minutes. 
Meanwhile, Prepare Zone fusilli according to 
package directions, (reduce cooking time by 5 
minutes). Drain and stir in with vegetables. 
Transfer into small baking dish coated with 
cooking spray. Sprinkle with cheeses. Cover and 
bake 10 minutes or until bubbly. Uncover and 
bake 5-10 minutes longer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
